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ARTHRITIS RESEARCH UK
Arthritis Research UK is the charity dedicated to stopping the 
devastating impact that arthritis has on people’s lives.  
Everything we do is focused on taking the pain away and keeping 
people active. Our remit covers all conditions which affect the 
joints, bones and muscles including osteoarthritis, rheumatoid 
arthritis, back pain and osteoporosis. We fund research into the 
cause, treatment and cure of arthritis, provide information on 
how to maintain healthy joints and bones and to live well with 
arthritis. We also champion the cause, influence policy change 
and work in partnership with others to achieve our aims. We 
depend on public support and the generosity of our donors to 
keep doing this vital work.
5
6 Musculoskeletal conditions and multimorbidity \ Forewords 
FOREWORDS
Professor Peter Kay 
National Clinical Director for  
Musculoskeletal Services  
NHS England
Increasing numbers of people are living with 
multiple long-term conditions. This, alongside 
an ageing population, will have a substantial 
impact on health and care services. With limited 
financial resources, we need to work differently 
to deliver good person-centred care.
Both the Five Year Forward View and the General 
Practice Forward View recognise the need for 
change. To move from a model which considers 
single diseases, to one which examines the 
holistic needs of a person with multiple 
long-term conditions. 
But for such a change to occur, it is important 
that we understand more about the prevalence 
and impact of living with multiple long-term 
conditions. In this report, Arthritis Research 
UK examines the impact of living with a 
musculoskeletal condition and other long-term 
conditions, and makes recommendations on 
what can be done differently.
Among people living with multimorbidity, 
musculoskeletal conditions such as osteoarthritis 
and back pain are very common. They cause 
pain and functional limitations which can impact 
on overall wellbeing and independence. And if 
musculoskeletal conditions are present as one of 
multiple long-term conditions, then they make 
overall life harder.
As we build metrics and tools to understand 
and improve quality of services for people with 
multiple long-term conditions, it’s important that 
we include domains such as pain and functional 
limitations, alongside capability to manage. We 
must also work across systems to ensure we 
have the appropriate data collected and available 
to understand the numbers and requirements of 
people living with multiple long-term conditions.
Finally, it’s clear that the impact of living with 
multiple long-term conditions stretches beyond 
health and care, to other parts of life such as 
employment, benefits and housing. There is a 
powerful case for increased collaboration to 
ensure that we truly identify and support what 
matters most to the person living with multiple 
long-term conditions.
I hope you find this an informative document 
that aids understanding of how the presence 
of a musculoskeletal disease impacts on overall 
health and wellbeing, and independence.
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The Global Burden of Disease Report highlighted 
an increase in the prevalence of musculoskeletal 
(MSK) conditions in the UK along with the number 
of years lived with disability. Recent trends in life 
expectancy in England highlight people are living 
longer, though many are doing so in poor health 
than ever and that makes achieving a good 
quality of life in later years even more important.
Population trends and surveys identify rising 
levels of obesity and inactivity both of which 
can be a causal factor and exacerbate the 
impact of some musculoskeletal conditions. 
Musculoskeletal conditions can be painful and 
distressing, causing a loss of confidence, dignity 
and independence. In some cases it can have 
quite severe consequences to the life chances 
of an individual through the loss of work, 
dependence on the state, family and friends. 
An ageing population that is forced to retire 
early due to ill health will increasingly affect the 
economic status of individuals and society. 
We need to focus our collaborative efforts on 
changing the burden of an MSK tide and act 
early to prevent, detect, treat and target public 
health interventions across the life course. Public 
Health England (PHE) has commissioned the 
development of economic tools to compare the 
return on investment of interventions for the 
prevention of major musculoskeletal conditions 
and the prevention of falls and fractures. There 
is a commitment to work with our partners to 
develop a systematic approach for the use of 
existing and new data that will help us to identify 
the prevalence of some MSK conditions across 
the different regions of the country in support 
of smarter commissioning and quality delivery 
outcome measures. 
People and places are integral to how we live, 
work and spend our leisure time, therefore we 
need to invest in the future to create healthy 
places, building on the evidence to inform how 
the built environment and the wider social 
determinants impact on musculoskeletal health. 
We are responding to evidence and listening 
to people with complex needs and mobilising 
our efforts by working collaboratively with 
stakeholders. There is consensus across the 
sector for an upstream approach targeting 
early intervention and healthier ageing across 
the life course to protect future generations. 
PHE has delivered a number of key tools and 
resources that will impact on the nation’s health 
going forward such as the ‘One You’ online 
self-assessment tool, the Falls and Fractures 
consensus statement and the commissioning 
of the health economics tool for MSK and falls 
and fractures.
The resources will be monitored and reviewed to 
evaluate the effectiveness, quality performance 
and achievement of public health outcomes. 
Employers and individuals will be supported to 
make informed decisions about how they can 
prevent, detect and access treatment at an 
early stage to achieve better health outcomes. 
PHE shares the commitment of partners to work 
collaboratively to influence and shape future 
policy, support opportunities to strengthen 
evidence and data to challenge the current 
landscape and change future practice. 
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Professor Chris Salisbury 
Professor of Primary Health Care 
Centre for Academic Primary Care 
University of Bristol
As life expectancy increases, more people  
are living with long-term health conditions  
such as arthritis, heart disease or lung disease. 
Many people don’t just have one of these 
conditions, they have several – a phenomenon 
known as multimorbidity. 
Having multimorbidity has a big impact on 
people’s lives. People with multimorbidity  
tend to have a worse quality of life, and often 
experience pain and disability. In particular, 
having multiple physical health problems can 
impact on mental health and also lead to  
social isolation. 
Unsurprisingly, people with multimorbidity  
are frequent users of the health service, 
accounting for a high proportion of general 
practice consultations and hospital admissions. 
This high level of need for health care also has 
an impact on the patients themselves, since 
they may have to swallow numerous tablets, 
follow special exercise regimes, and attend 
numerous appointments.
Medicine has traditionally been organised around 
diseases, so we have services designed for 
patients with Alzheimer’s disease, or arthritis, 
or angina. But this approach doesn’t work well 
for patients with Alzheimer’s and arthritis and 
angina. These patients with multimorbidity are 
now the norm rather than the exception, and  
we need to think about healthcare in a new  
and more holistic way.
So it is very good news that Arthritis Research 
UK, one of the major ‘disease-based’ charities, 
is leading the way in thinking about how the 
concept of multimorbidity impacts on their work 
with people with musculoskeletal conditions. 
These conditions are extremely common and 
can be the main cause of impaired quality of life 
in people with multimorbidity. Perhaps because 
they are so common, and because they are 
sometimes seen as a natural consequence of 
ageing, conditions such as arthritis have not 
received the attention they deserve. 
This report presents useful, practical 
recommendations to policymakers at 
local and national levels. Acting on these 
recommendations would lead to huge  
benefits for the many people with 
multimorbidity including arthritis 
and other musculoskeletal problems.
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Arthritis Research UK
Arthritis attacks what it means to live. It causes 
pain, fatigue and often anxiety or depression. 
For over 8.75 million people living with the pain 
of osteoarthritis, and nine million with back pain, 
the limitations of arthritis and musculoskeletal 
conditions make simple activities a daily struggle. 
From going to work, and interacting with family, to 
socialising with friends, or popping to the shops, 
people with arthritis cannot take these moments 
for granted. On top of the effects to the individual, 
there is a major impact on health and care 
services, and the economy. 
Arthritis Research UK is passionate about 
ensuring that people can live well with arthritis. 
But too often arthritis is misunderstood and not 
recognised. People with arthritis often hide their 
pain or their health and care professionals suggest 
nothing can be done. Six out of ten people with 
arthritis don’t believe their condition is a high 
priority for the NHS. Arthritis is also overlooked 
in local areas, regularly being missed out from 
local needs assessments. These omissions waste 
opportunities to improve people’s musculoskeletal 
health, preventing people from enjoying a good 
quality of life and remaining independent. 
Musculoskeletal conditions are often found among 
people who live with other long-term conditions. 
For instance, by 65 years of age, almost five out 
of ten people with a heart, lung or mental health 
problem also have a musculoskeletal condition. 
With the numbers of people living with multiple 
long-term conditions projected to grow, it’s 
important that we understand the changing 
needs of this group and ensure they  
are met effectively. 
Over the last two years Arthritis Research UK 
has examined these issues in depth. We held a 
roundtable, spoke to people with arthritis and other 
long-term conditions, healthcare professionals and 
researchers, conducted a literature review, and 
analysed the General Practice Patient Survey. All of 
this helped us understand more about the nature 
and impact of living with arthritis when combined 
with other long-term conditions. We reached three 
key observations:
Firstly, musculoskeletal conditions are very 
common and are often present where there are 
other long-term conditions. Secondly, they ruin 
quality of life. The presence of any long-term 
condition is associated with a drop in quality  
of life, but when arthritis or back pain is present 
as one of the long-term conditions, the drop is 
greater. Lastly, the pain and functional limitations 
of arthritis make it harder to cope when living with 
multiple long-term conditions. Simple everyday 
tasks such as grasping small objects, standing or 
sitting can be difficult with arthritis. As life with 
multiple long-term conditions normally means 
taking tablets, changing dressings, attending 
health appointments and undertaking exercise, 
this all becomes more challenging as arthritis 
limits a person’s ability to walk, bend, sit, or often 
use their hands. 
It’s clear that good musculoskeletal health 
underpins people’s ability to live well and 
independently with multiple long-term conditions. 
As systems change, and new collaborations 
develop to meet the needs of people with 
multiple long-term conditions, it’s vital that the 
needs of people with arthritis are considered and 
included. Pain and functional abilities should also 
be included in metrics, tools and plans for people 
with multimorbidity. 
Arthritis Research UK is keen to build on existing 
partnerships, and develop new collaborations. 
We wish to ensure that arthritis – whether it 
is present by itself or among other long-term 
conditions - does not limit people’s lives.
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million people across the UK  
have musculoskeletal conditions  
such as arthritis or back pain.
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Good musculoskeletal health means that the 
muscles, joints and bones work well together 
without pain. Musculoskeletal health is essential 
for overall health and wellbeing. Without it, it is 
impossible to live independently, or well. 
Musculoskeletal conditions such as arthritis or 
back pain affect around 10 million people across 
the UK, causing pain, stiffness, loss of mobility and 
dexterity, and depression. These symptoms affect 
every aspect of life: family, work and social. 
It is now common for people to live with two or 
more long-term conditions. This multimorbidity 
reduces quality of life, worsens health 
outcomes and increases mortality. People with 
multimorbidity rely more heavily on health and 
care services. 
People living with multimorbidity often have a 
musculoskeletal condition as one of their health 
problems. Because health, care and public health 
systems often do not identify or prioritise these 
painful conditions, substantial opportunities to 
improve people’s health are missed.
Without good musculoskeletal health, everyday 
life becomes harder. People are left living in pain. 
With reduced mobility and dexterity people 
struggle with everyday activities such as dressing 
or preparing food. 
Living well with multimorbidity requires people 
to carry out a litany of complex tasks: monitoring 
symptoms, managing medications, coordinating 
carers and attending appointments. The onset, 
or worsening, of arthritis or back pain can 
completely undermine people’s ability to cope 
with their health problems. Without intervention 
and support, people can reach a tipping point 
beyond which they can no longer manage their 
multimorbidity, leading to a spiralling decline in 
their physical and mental health. 
This is neither acceptable nor necessary. 
Good musculoskeletal health underpins living  
well and independently with multimorbidity.  
By recognising musculoskeletal health as part of 
multimorbidity, and ensuring that people receive 
appropriate advice, support and treatment for 
their musculoskeletal problems, we can prevent 
many people from losing their health and 
wellbeing, their independence and their dignity. 
Policymakers should ensure that consideration 
and assessment of pain and functional abilities 
are included in tools and interventions to 
identify and support people with multimorbidity. 
Musculoskeletal data should be captured and 
its quality improved; this information should be 
used in multimorbidity analyses and planning. 
Healthcare professionals should consider and 
discuss pain and functional limitations in their 
care and support planning conversations. And 
other professionals and the public should be 
empowered to consider musculoskeletal health 
as part of multimorbidity through relevant public 
health resources. 
The voluntary sector has a role to play in building 
partnerships to ensure the changing needs of 
their beneficiaries are met. And research funders 
have an opportunity to build a flourishing 
research agenda into multimorbidity. 
This report articulates why policymakers, 
charities and research funders should include 
musculoskeletal health when making plans to 
support people living with multimorbidity. It 
considers the impact of musculoskeletal diseases 
and the importance of recognition of such 
conditions when they are one of many long-term 
conditions. It brings together learnings from a 
roundtable, a literature review, conversations 
with people with multimorbidity, healthcare 
professionals and researchers, and an analysis  
of the GP Patient Survey. 
Arthritis Research UK would like this to be the 
beginning of new collaborations and partnerships 
to ensure the changing needs of people living 
with many long-term conditions including 
arthritis are met.
EXECUTIVE SUMMARY
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1 Identification: NHS England should ensure that any metrics and tools used in multimorbidity programmes include monitoring and measuring of pain 
and its impact, functional abilities 
and capability to manage.
Health promotion: Public Health 
England should ensure that its 
information, programmes and 
campaigns reflect and address the 
needs of the growing numbers of 
people living with multimorbidity 
including musculoskeletal conditions.
Voluntary sector: Disease-specific 
charities and their respective coalitions 
should collaborate in recognising 
that many people now live with 
multimorbidity and work together 
to develop resources, programmes, 
research and partnerships to meet the 
changing needs of people with multiple 
long-term conditions.
Research agenda: Research funders, 
such as the National Institute 
for Health Research, should work 
with partners to ensure there is a 
flourishing research agenda covering 
multimorbidity, which includes 
common conditions such 
as musculoskeletal conditions.
2 Data collection: Public Health England should work with other national bodies to ensure that data collection, analysis and publication raises awareness of 
multimorbidity and the relevance  
of its musculoskeletal component.
3 Planning and commissioning: Local planners and commissioners of health  and care services should identify, segment and understand the needs 
and requirements of people living 
with musculoskeletal conditions and 
multimorbidity in their population, 
and publish these in local documents 
such as their Joint Strategic Needs 
Assessments and Joint Health and 
Wellbeing Strategies.
4 Care and support planning: Healthcare providers should ensure that people with multimorbidity can take part in a care and support planning process 
using standardised tools to explore and 
record pain, functional limitations and 
how these affect their daily activities.
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1.1  
Purpose of report
The purpose of this report is to explore why 
and how musculoskeletal health should be 
considered as part of multimorbidity.  
It examines why the presence of musculoskeletal 
disease – such as osteoarthritis or back pain 
– can have an overall impact on the health, 
wellbeing and independence of a person living 
with multimorbidity. 
It explores why musculoskeletal conditions 
are often overlooked as part of multimorbidity 
and considers the implications of living with 
a musculoskeletal condition alongside other 
long-term conditions. This report suggests 
system changes so that individuals’ situations 
can be recognised, and action can be taken 
to mitigate the impact of living with a 
musculoskeletal disease and multimorbidity.
1.2  
Scope of report
This report focuses on people living with two or 
more long-term conditions (conditions which are 
persistent and recurrent), a phenomenon known 
as ‘multimorbidity’.1 Case studies and data about 
people living with musculoskeletal conditions 
and other long-term conditions are included 
throughout, including a new analysis of the 
GP Patient Survey (GPPS) carried out by 
Arthritis Research UK. 
This report does not consider the needs of 
people living with frailty. Best practice guidelines 
for the care and management of people living 
with frailty have been developed and there is a 
greater understanding of the concept of frailty.2 
However, the understanding of the need for good 
musculoskeletal health for people living with 
multimorbidity is underdeveloped.
THE PURPOSE OF THIS 
REPORT IS TO EXPLORE 
WHY AND HOW 
MUSCULOSKELETAL 
HEALTH SHOULD BE 
CONSIDERED AS PART 
OF MULTIMORBIDITY.
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1.3  
Musculoskeletal health
Musculoskeletal health means more than the 
absence of a musculoskeletal condition. Good 
musculoskeletal health means that the muscles, 
joints and bones work well together without pain. 
People with good musculoskeletal health can 
carry out the activities they want to with ease 
and without discomfort. It is possible to have 
poor musculoskeletal health without having a 
specific musculoskeletal condition.
Several factors come together to produce 
musculoskeletal health. The joints and spine need 
to be stable and supple in order to support the 
body and carry out a wide range of movements. 
Muscles need to be strong enough to provide the 
power to move. Bones need to be sturdy enough 
to withstand the normal knocks of everyday living 
without breaking. A healthy nervous system  
is needed to oversee all this activity, providing 
co-ordination and balance. Good mental health 
is required to provide energy and motivation to 
be physically active. What’s more, all this should 
happen without pain, stiffness or fatigue. 
Coordination 
and balance
Sturdy 
bones
Strong 
muscles
Stable joints
and spine
Supple joints 
and spine
No
 pa
in  •
  No stif
fness  •  No fatigue
Good mental heal
th
Figure 1 Factors comprising musculoskeletal health4
Ideally it should happen throughout someone’s 
life, so people of all ages can enjoy good 
musculoskeletal health. For more information, 
please see Arthritis Research UK’s guide 
Musculoskeletal health: a public health approach. 
Good musculoskeletal health is important 
throughout life
Good musculoskeletal health is an important 
component of maintaining a person’s functional 
abilities throughout the life course. It is also 
fundamental to healthy ageing, which the World 
Health Organization (WHO) has characterised  
as ‘the process of developing and maintaining 
the functional ability that enables wellbeing 
in older age’.3 
Social perceptions of ageing are gradually 
changing. People increasingly expect to lead 
independent, active, pain-free lives in their older 
years. For many people this includes remaining 
part of the workforce. For most this includes  
an active retirement, without the fear of 
pain and falls. 
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1.4  
Musculoskeletal conditions and their impact on health and wellbeing
Musculoskeletal conditions are disorders of the bones, muscles and spine, as well as 
autoimmune conditions such as lupus. Musculoskeletal conditions interfere with people’s 
ability to carry out their normal daily activities. Common symptoms include pain, stiffness and 
a loss of mobility and dexterity. The symptoms can fluctuate over time. The pain, distress and 
functional limitations caused by these conditions ruin quality of life, robbing people of their 
independence and impairing their ability to participate in family, social and working life. 
Figure 2 Three groups of musculoskeletal conditions
Group 1: Inflammatory conditions
2: Conditions of 
musculoskeletal pain
3: Osteoporosis and  
fragility fractures
Example Rheumatoid arthritis.
Osteoarthritis,  
back pain.
Fracture after 
a fall from a 
standing height.a 
Age Any. More common with 
rising age.
Mainly affects 
older people. 
Progression Often rapid onset. Gradual onset. Osteoporosis is a 
gradual weakening 
of bone. Fragility 
fractures are sudden 
discrete events.
Prevalence Common (e.g. 
around 400,000 
adults in the UK 
have rheumatoid 
arthritis).5
Very common (e.g. 
8.75 million people 
in the UK have 
sought treatment 
for osteoarthritis).6
Common (e.g. 
around 89,000 hip 
fragility fractures 
occur each year in 
the UK).7
Symptoms Common musculoskeletal symptoms  
include pain, joint stiffness and limitation  
of movement. Symptoms often fluctuate  
in severity over time.
Osteoporosis itself  
is painless. Fragility 
fractures are painful 
and disabling.
Extent of disease Can affect any part 
of the body including 
skin, eyes and 
internal organs.
Affects the 
joints, spine and 
pain system.
Hip, wrist and spinal 
bones are the most 
common sites of 
fractures.
a  Osteoporosis is a condition of bone weakening which in itself is painless. Fragility fractures caused by osteoporosis happen 
when frail bones break, causing pain and disability. Bone fractures can also occur due to trauma or injury.
Broadly, there are three groups of musculoskeletal conditions: inflammatory conditions, conditions 
of musculoskeletal pain, and osteoporosis and fragility fractures. Figure two explores each of these 
groups in more detail.
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Main treatment 
location 
Urgent specialist 
treatment is 
needed, and usually 
provided in hospital 
outpatients.
Primary/community 
care for most 
people. Joint 
replacement 
requires hospital 
admission.
Primary care for 
prevention.
Hospital for 
treatment of 
fractures.
Medical treatment Medication to 
suppress the 
immune system.
Pain management. 
Support to maintain 
healthy body weight. 
For severe cases 
joint replacement 
may be necessary.
Bone-strengthening 
drugs. 
Fractures may 
require surgery.
Physical activity 
benefits
Generic, self-
determined and 
prescribed exercises 
are important 
adjunct to medical 
therapy.
Generic, self-
determined and 
prescribed exercises 
are main treatment 
approach.
Generic, self-
determined and 
prescribed exercises 
prevent falls, 
strengthen bone and 
enhance recovery 
after a fracture.
Modifiable risk 
factorsb 
Smoking. Injury, obesity, 
physical inactivity.
Smoking, alcohol 
intake, poor 
nutrition including 
insufficient vitamin 
D, physical inactivity.
Group 1: Inflammatory conditions
2: Conditions of 
musculoskeletal pain
3: Osteoporosis and  
fragility fractures
b Non-modifiable risk factors include age, sex and genetics.
Figure 2 Three groups of musculoskeletal conditions continued...
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1.5  
Multimorbidity: living with two  
or more long-term conditions 
Multimorbidity refers to the experience of two 
or more long-term conditions.1 Multimorbidity 
encompasses physical and mental health. 
Overall, nearly four out of 10 people (36%) with 
multimorbidity are living with a physical and a 
mental health condition.8 Sometimes people 
also use the term ‘comorbidity’ to refer to any 
additional conditions that people may have, 
beyond the main one being addressed. 
Within multimorbidity there can be different 
relationships between conditions. People may 
develop two long-term conditions independently 
of each other, for example a person having 
both osteoarthritis and asthma. Sometimes, a 
health condition can increase the likelihood of 
developing another as in rheumatoid arthritis 
where there is an increased risk of cardiovascular 
disease.9 In other cases, one long-term condition 
exacerbates the impact of another – this is seen 
with painful conditions such as back pain which 
lead to, and are worsened by, depression.10 
Finally, there are conditions which share causal 
factors, such as obesity which increases the 
risk of developing type 2 diabetes11 
and osteoarthritis.4 
MULTIMORBIDITY:  
A person living with 
multimorbidity has 
two or more long-term 
chronic conditions such as 
osteoarthritis and asthma. 
COMORBIDITY:  
Comorbidity refers to 
any additional conditions 
that people may have, 
beyond the main one 
being addressed.
Figure 3  Definitions of multimorbidity  
and comorbidity
 Among people over 45 years of age who report living with a 
major long-term condition, more than 3 out of 10 also have 
a musculoskeletal condition.
 Four out of five people with osteoarthritis have at least 
one other long-term condition such as hypertension, 
cardiovascular disease or depression.
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1.6  
Characteristics of frailty 
Although there is no accepted clinical definition 
of frailty, unintentional weight loss, sarcopenia 
(loss of muscle mass and strength), self-reported 
exhaustion and loss of mental capacity are all 
recognised characteristics of frailty.12, 13 Frailty is 
increasingly seen as a long-term condition.14 
For people who are frail, even a minor event can 
trigger a rapid decline in health. For example, a 
person with frailty could live independently until 
a fall triggers a swift and ongoing deterioration 
in health. 
Frailty is often, but not exclusively, linked to 
the ageing process. It is estimated that 10% of 
people over 65 are frail, and 25%–50% of those 
aged 85 or over experience frailty.2
People living with frailty have the highest rates 
of unplanned admissions to hospital among 
users of health and care services.15 Geriatricians 
work closely with GPs and other healthcare 
professionals to support the holistic care and 
management of the health and wellbeing of 
people living with frailty.
1.7  
Overlap between frailty  
and multimorbidity
Frailty and multimorbidity are two separate 
concepts and seek to describe two 
distinct phenomena.
There are overlaps: some people live with both 
frailty and multimorbidity. For example, an 
80-year-old person may live with sarcopenia and 
incontinence (characteristics of frailty), and also 
live with the conditions of osteoarthritis, heart 
disease and type 2 diabetes (multimorbidity). 
As frailty and multimorbidity increase with 
age, healthcare systems will need to cope 
with increasing numbers of people with these 
conditions in an ageing population. 
But there are cases where a person lives with 
multimorbidity but is not frail. For example, 
a 45-year-old person may have asthma, 
osteoarthritis and type 2 diabetes but does not 
experience frailty. This report focuses on the 
needs of non-frail people with multimorbidity, 
and the support and services they need.
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Musculoskeletal conditions and multimorbidity – in numbers 
Musculoskeletal conditions
Among UK primary care patients living with 
10 common long-term conditions,painful 
conditions are a frequent comorbidity.
Four out of five people with osteoarthritis 
have at least one other long-term  
condition such as hypertension, 
cardiovascular disease or depression.
Among people over 45 years of age who 
report living with a major long-term 
condition, more than three out of 10 
also have a musculoskeletal condition.
Multimorbidity
By 65 years of age, most people have 
multimorbidity. 
Over half of the number of people who 
live with multimorbidity are under 
65 years of age.
Women have higher rates of multimorbidity 
than men.
36% of people with multimorbidity have 
physical and mental health conditions.
The presence of any long-term condition 
is associated with a drop in quality of life 
(self-reported Quality of Life score of 0.79), 
but if arthritis or back pain is present as 
one of the long-term conditions the drop 
is greater (self-reported Quality of Life 
score of 0.71). 
By 2025 there will be an estimated 9.1 
million people living with one or more  
long-term conditions in the UK.
of people with 
multimorbidity have 
physical and mental 
health conditions
36%
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2.1  
Musculoskeletal conditions  
are very common 
Musculoskeletal conditions affect millions of 
people in the UK. The prevalence is highest 
among women, older people and those from 
the most deprived communities. Painful 
musculoskeletal conditions are the largest single 
cause of years lived with disability (YLDs) and 
the third largest cause of disability adjusted 
life years (DALYs).16
Inflammatory conditions Conditions of  musculoskeletal pain
Osteoporosis and  
fragility fractures
400,000 people live with 
rheumatoid arthritis in 
the UK.5
8.75 million people have 
sought treatment for 
osteoarthritis, the most 
common form of arthritis, 
across the UK.
Women account for 
almost six out of 10 people 
seeking treatment.6
One in five adults over 
45 in England have knee 
osteoarthritis and one in nine 
adults have osteoarthritis of 
the hip.17
Around 9 million people in 
England have persistent back 
pain, of which around 5.5 
million experience severe  
back pain.17
Each year, 89,000 people 
across the UK fracture  
their hip.7
Figure 4 Prevalence of musculoskeletal conditions
1 in 5 adults over 45 
in England have knee 
osteoarthritis
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Relationship between deprivation, age and prevalence
The prevalence of arthritis increases with rising age. There is also a significant relationship between 
deprivation and numbers of people living with chronic pain conditions including arthritis and 
back pain.18
Future prevalence
The prevalence of musculoskeletal conditions 
will increase because of the ageing population, 
and growing levels of obesity and physical 
inactivity. These are all major risk factors in the 
development of a musculoskeletal condition.4
In 2010, there were 4.7 million people living with 
knee osteoarthritis, the most common site in 
the body for osteoarthritis to develop. Obesity 
is a significant risk factor for knee osteoarthritis. 
When the impact of the ageing population and a 
growing obese population is considered, by 2035 
there are expected to be 8.3 million people living 
with knee osteoarthritis.6
Figure 5  Impact of age and deprivation on prevalence of arthritis among people aged 45 years  
and over in Englandc,19 
Figure 6  Impact of age and deprivation on prevalence of back pain among people aged  
45 years and over in England19
Most deprived
Level of deprivation
Percentage Percentage
Level of deprivation
Least deprived
10.6%
36.2%
33.6%
21.5%
23.1%
44.4%
65-74
75+
45-64
Most deprived
Level of deprivation
Percentage Percentage
Level of deprivation
Least deprived
9.1%
19.3%
15.1%
17.7%
11.8%
18.6%
65-74
75+
45-64
People in the most deprived 
areas are much more likely to 
report arthritis than people 
in equivalent age groups who 
live in less deprived areas.19 
Among people of working age 
(45–64 years), the prevalence 
is more than double in the 
most deprived areas (21.5%) 
compared to the least 
deprived areas (10.6%).19
People in the most deprived 
areas are more likely to 
report back pain at every 
age compared to the least 
deprived. Those people in 
the most deprived areas 
experience back pain at a 
relatively young age: people of 
working age (45–64 years) are 
almost twice as likely 
to report back pain (17.7%) as 
those from the least deprived 
areas (9.1%).19
c  Data from the GP Patient Survey has been used to conduct these analyses. As musculoskeletal problems are often poorly coded in GP records and are therefore 
likely to be under-reported the GP Patient Survey is a useful alternative data source. See Section 7.0 for details about the methods used.
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2.2 
Musculoskeletal conditions impact  
on all parts of a person’s life
Arthritis affects all aspects of a person’s life: 
home life, relationships, finances and work. 
The impact of musculoskeletal conditions is 
therefore best understood through a bio-psycho-
social approach. 
Musculoskeletal conditions cause pain, joint 
stiffness and limitations of movement. They 
fluctuate over time and can be unpredictable. 
They cause distress, not just because of the 
physical limitations they impose but because 
they alter a person’s perception of themselves, 
of their ability to cope and of the world 
around them.
Musculoskeletal conditions can have a 
devastating impact on quality of life: they ruin it.
Impact on daily life
Pain is one of the main symptoms of arthritis. In 
a 2015 survey of people with arthritisd, eight out 
of 10 people living with arthritis (78%) said they 
experience pain most days, with nearly six out of 
10 people (57%) with arthritis experiencing pain 
every day.20
Pain makes everyday activities more difficult to 
cope with. Arthritis limits a person’s ability to do 
the essential tasks of daily life. Basic activities 
(activities of daily living or ADLs) such as bathing, 
dressing and getting out of bed or a chair can 
become a struggle. Instrumental activities of 
daily living (IADLs) such as housework, preparing 
meals and shopping are also affected. A person 
with arthritis may need to adapt their home or 
car to mitigate functional limitations. 
Impact on family life
A person’s pain will have an impact on their 
perceptions of their own vulnerability and desire 
for support. Such pain may result in people with 
arthritis hiding the extent of the pain from their 
loved ones. Five out of 10 (53%) people with 
arthritis feel they are a nuisance to their family, 
which rises to eight out of 10 (81%) among those 
with the most severe arthritis.20 Some people 
may need support from family, friends 
or carers (formal or informal) so they 
can remain independent. 
Impact on mental health
Living with painful arthritis often causes fatigue 
and depression. A person’s mood, energy levels, 
ability to sleep and daily routine can all be 
affected. As a person changes their schedule to 
cope, giving up hobbies and social time, and in 
severe cases their work, they can lose confidence 
and self-esteem. This, in turn, reduces their 
quality of life. 
Lack of recognition and understanding 
by society
People with arthritis feel invisible and that their 
condition is not recognised or understood. Eight 
out of 10 people with arthritis (78%) agree that 
society does not understand their condition 
because it ‘doesn’t look’ like they have a serious 
condition, and six out of 10 people with arthritis 
(62%) believe that arthritis is not a high priority 
for the NHS.20
Although arthritis can strike at any age, people 
with arthritis feel that society views their 
condition as one that only affects older people. 
Nine out of 10 people with arthritis (89%) 
agree that society views arthritis as an 
‘old person’s disease’.20
Some people find the ‘invisibility’ of arthritis 
a challenge, because others cannot see why 
they are struggling with tasks of dexterity or 
movement. In other cases, a person’s arthritis 
may be visible: for example, a person with severe 
knee osteoarthritis may limp or the shape of the 
hand of a person with hand osteoarthritis will 
visibly change. It might be assumed that they 
are unable to carry out certain activities, and 
the need to use a stick, for example, can 
make people feel stigmatised.
d For methods, please see Section 7. 
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YOU CAN’T 
ELIMINATE THE 
PAIN. IT’S THERE 
ALL THE TIME. 
ALL I WANT TO 
DO IS GET OUT 
OF THE PAIN 
Damian, 59  
living with osteoarthritis20
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Work, income and finances
Arthritis has an impact on a person’s ability to 
work and therefore affects their income. For 
example, people who find standing and walking 
painful can have difficulty travelling to work. 
Stiffness and pain in the arms or hands can 
make everyday tasks such as keyboard work or 
grasping tools difficult. Ongoing pain can lead to 
low mood, which affects self-esteem and leads 
to a reduced ability to carry out tasks. This in turn 
has a negative impact on a person’s confidence 
and motivation, and therefore on the ability 
to work.
People with musculoskeletal conditions are less 
likely to be employed than people in good health, 
and are more likely to retire early.21 Six out of 10 
people (59.7%) with a musculoskeletal condition 
are in work, compared to seven out of 10 people 
(73.5%) without a long-term health problem or 
disability.22 One in four people with arthritis (25%) 
give up work or take early retirement.20 There 
is an arthritis work gap: the employment rate 
among people with arthritis is 20% lower than 
among people with no condition or disability. 
This means that 600,000 people with arthritis 
are currently missing out on the opportunity 
to work.23
But most people with arthritis want to work, and 
with the appropriate support from their employer 
and flexible working arrangements, they can. For 
more information, please see Arthritis Research 
UK’s Working with arthritis report.24
Entitlement to benefits
Some people with arthritis will be unable to 
work owing to the severity of their condition 
and its impact. However, there is low awareness 
among people with arthritis about the benefits 
to which they are entitled: nearly three out 
of 10 (27%) are not aware of their potential 
entitlements.20 The fluctuating nature of arthritis 
creates an additional hurdle when people are 
being assessed for benefit entitlements. People’s 
functional capabilities may vary over time, and 
therefore accurately capturing fitness to work 
through a stand-alone assessment is difficult. 
Additional costs
Overall, about seven in 10 (73%) people with 
severe arthritis struggle with their financial 
stability relative to their income, compared to 
only 6% of those with no functional limitations.20 
Nearly half of people with arthritis (48%) cannot 
afford all the treatments they want or need.20 
This rises to nearly eight out of 10 (78%) among 
those struggling with their income.20 Many 
treatments for a musculoskeletal condition 
can incur a financial cost such as massage, 
physiotherapy and equipment around the 
home.e Overall, the additional cost of living with 
osteoarthritis is estimated to be £480 a year.25
e  Physiotherapy is available on the NHS. Depending on availability and waiting times, many people with arthritis and back pain often supplement this with additional 
paid-for physiotherapy sessions. 
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I WAS DIAGNOSED WITH 
PSORIATIC ARTHRITIS 11 YEARS 
AGO… The nature of the job meant chairing 
large meetings, which means standing for long 
periods of time. They allowed me to stop doing 
these meetings and I had no time off for over 
a year, but now the service cannot manage 
it. I have been given time to try my new 
medication and see if I can get back up to 
speed. I do not imagine I will ever get back 
to chairing two-hour meetings so it looks 
like early retirement. I am 46. I have huge 
experience and skills yet my inability to 
stand means I could lose the job I love. 
It is soul destroying.
STACEY’S STORY
Stacey works for a local council; 
she has psoriatic arthritis.24
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2.3  
Musculoskeletal conditions have a large 
impact on health and care services, 
society and the economy 
Health and care services
Musculoskeletal conditions have a considerable 
impact on health and care services owing to the 
large numbers affected and the complexity of 
their needs. 
As musculoskeletal conditions are often 
life-long conditions, people with arthritis may 
use health and care services for many decades. 
Musculoskeletal conditions account for the third 
largest NHS programme budget, around £4.7 
billion annually in England.26
In primary care, one in five of the general 
population consults their GP about a 
musculoskeletal problem each year.27 
Musculoskeletal problems are addressed in one 
in eight (12%) GP appointments.28 Across the UK, 
8.75 million people have sought treatment for 
osteoarthritis, the most common form of arthritis 
(this constitutes a third of all people over 45 years 
of age).6 People with arthritis are substantial 
users of physiotherapy services, as physiotherapy 
can help to substantially reduce pain and restore 
movement and function.
Around £4 billion of the NHS musculoskeletal 
programme budget is spent on secondary care.29 
For people with severe osteoarthritis, an elective 
(planned) hip or knee replacement can reduce 
pain and give back a person’s mobility and 
independence. More than 98,211 hip replacement 
procedures and 104,695 knee replacements 
were undertaken in the NHS in 2015 alone.30
Fragility fractures and osteoporosis are common 
and affect large numbers of people. Each year 
89,000 people across the UK fracture their 
hip and will require emergency surgery.7
Social care can support people with 
musculoskeletal conditions to remain 
independent. Just over half (51%) of gross local 
authority expenditure on adult social care is on 
people over 65 years, a substantial number of 
whom will have a musculoskeletal condition.31
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Figure 7 Employment status by long-term condition among people 45–64 years of age in England19
The economy and society
Musculoskeletal conditions have a massive direct 
impact on the working-age population. In 2015, 
32.4 million working days were lost because of 
musculoskeletal conditions.32
People reporting a musculoskeletal condition 
are less likely to be in full-time paid work (44.5%) 
than those with any other long-term condition 
other than a mental health condition (28%) or a 
recent cancer experience (40.4%).19 The presence 
of a musculoskeletal condition is the third-most 
common reason for people reporting being 
permanently sick or disabled (the most common 
reasons are because of a mental health 
condition or a recent cancer experience).19
The indirect costs (inability to work, absenteeism, 
reduced productivity and informal care) of 
rheumatoid arthritis and osteoarthritis combined 
are £14.8 billion each year.33 Back pain is 
responsible for £10 billion of indirect costs to 
the economy in the UK each year.34 Rheumatoid 
arthritis is estimated to cost the economy 
£3.8–4.8 billion.35
There are an estimated 2.4 million adults in 
the UK who have caring responsibilities for 
their children and for their parents (sometimes 
referred to as the ‘sandwich generation’).36 
Someone who is caring for a parent with severe 
osteoarthritis will experience a severe impact 
on their life as they try to balance family 
commitments with work.37
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of the general population consults their GP about 
a musculoskeletal problem each year.27
8.75m 
people have sought treatment for osteoarthritis 
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2.4  
People with musculoskeletal conditions 
use many different treatments 
The purpose of treatment is to maximise quality 
of life by reducing joint pain and stiffness, 
limiting progression of joint damage and 
enabling functional ability.38 The treatment 
approach will vary depending on the person, the 
severity of their condition and their capability to 
manage independently. 
Non-drug interventions
People with arthritis can benefit from a range of 
non-drug interventions:
Physical activity: exercise generally 
reduces overall pain for people with a 
musculoskeletal condition.4 Activities 
should include aerobic activity and 
muscle-strengthening exercises. 
Physiotherapy: physiotherapy aims to 
substantially reduce pain, and restore 
movement and function for people with a 
musculoskeletal condition.
Rehabilitation: this personalised, interactive 
and collaborative process, including 
supported self-management, enables 
an individual to maximise their potential 
to live a full and active life.
Weight loss: obesity directly damages 
weight-bearing joints. For people with 
osteoarthritis, relatively modest weight 
loss, particularly when combined with 
increased physical activity, reduces 
pain and disability.39,40,41,42
Talking therapies: psychological 
interventions such as Cognitive Behavioural 
Therapy (CBT) and mindfulness-based 
approaches can help people with arthritis 
manage their pain and fatigue. 
Information and support: people with 
arthritis require accurate information about 
their conditions, symptom management 
and local self-management courses and 
support networks. 
Modifications: appropriate modifications 
to the home such as grab rails and support 
from social care can aid independent living. 
Complementary therapies: alongside 
conventional treatments, these can 
help alleviate pain.43
Medication
People with osteoarthritis and back pain may 
use topical or oral medication to ease joint pain 
and stiffness, and reduce inflammation. For 
some people, there may be a place for opioid-
based treatments, or drugs to combat resulting 
nerve pain such as sciatica. 
People diagnosed with osteoporosis 
should take vitamin D, calcium and bone-
strengthening medication.44
People with inflammatory conditions such as 
rheumatoid arthritis generally need specialist 
continual drug treatment, and early diagnosis 
and intensive treatment can prevent lifelong 
pain and disability. 
Surgery
For people living in constant pain from arthritis, 
joint replacement surgery is a highly effective 
treatment which can restore quality of life. 
Severe osteoarthritis is the cause of the majority 
of initial hip and knee joint replacements. 
A fragility fracture requires prompt assessment 
in A&E and may need rapid surgery, particularly 
for hip fractures, which can be life-threatening 
without surgery.
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2.5  
People with musculoskeletal conditions 
experience barriers accessing treatments
People with a musculoskeletal condition may 
not be readily able to access treatments 
which benefit their condition owing to non-
clinical reasons. 
Non-drug interventions
There is an inbuilt bias towards accessing drug-
based treatment via the health system. When 
NICE recommends a non-drug intervention for 
people with arthritis, such as a physiotherapy 
review, the NHS is under no obligation to provide 
this. This means that ensuring access and 
provision of local non-drug interventions and 
services may vary depending on local priorities. 
Medication
People with inflammatory arthritis often 
experience delays accessing treatments. 
Currently, only 37% of people diagnosed with 
inflammatory arthritis are seen in rheumatology 
services within the recommended time of three 
weeks from referral.45,46 There is considerable 
variation in length of time to access specialist 
care across England and Wales.46
Surgery
Financial restraints in the health service have led 
to non-clinical restrictions being proposed for 
elective surgery including joint replacements.47,48 
Best practice guidelines from the National 
Institute for Health and Care Excellence (NICE) 
makes clear that people experiencing joint 
pain which has a substantial impact on quality 
of life should be considered for referral for a 
joint replacement. A decision to delay such an 
operation should be based on clinical need and  
a person’s preferences.
EXERCISE GENERALLY 
REDUCES PAIN FOR 
PEOPLE WITH A 
MUSCULOSKELETAL 
CONDITION.
MULTIMORBIDITY
3.0
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3.0
3.1  
The number of people living with 
multimorbidity is growing
Currently, the majority of people aged over 65 
years of age are living with multimorbidity.8 
But multimorbidity is not exclusively an issue 
of ageing. The number of people living with 
multimorbidity is greater among those under 
65 years: over half of the number of people with 
multimorbidity are under the age of 65 years.8
In Scotland, the prevalence of people with 
multimorbidity increases from 64.9% among 
those aged 65–84 years to 81.5% among those 
aged 85 years or over.8
The GP Patient Survey found that just over two 
out of 10 adults (23%) has multimorbidity, rising 
to five out of 10 (51%) of over 65 year olds.49 An 
analysis of the Quality and Outcomes Framework 
(QoF) in primary care found that 16% of adults 
has multimorbidity,g which rises to nearly six out 
of 10 (58%) when a broader list of long-term 
conditions was used.50
A number of risk factors have an impact on 
the prevalence of multimorbidity including 
age, socioeconomic class and gender.51 There 
is limited data available, but generally the 
prevalence of multimorbidity is higher in:
Women
People living in deprived areas
Older people49, 50
The impact of multimorbidity falls 
disproportionally on those from poorer 
backgrounds. There is a strong association 
between multimorbidity and deprivation: 
people in the most deprived areas develop 
multimorbidity 10–15 years earlier compared 
to those in the least deprived.8 Furthermore, 
multimorbidity that includes a mental health 
condition is particularly associated with people 
in the most deprived areas (11% prevalence of 
physical and mental health conditions) compared 
to the least deprived (5.9%).8
Figure 8 Prevalence of multimorbidity in the Scottish populationf 8
Age (in years) Number of people
Percentage of 
population with 
multimorbidity
Mean number  
of morbidities
0–24 479, 156 1.9% 0.16
25–44 508, 389 11.3% 0.50
45–64 473, 127 30.4% 1.18
65–84 254, 600 64.9% 2.60
≥85 36, 569 81.5% 3.62
f The data used was extracted from 314 medical practices in Scotland in March 2007. 
g  Whilst rheumatoid arthritis and osteoporosis are part of the QoF, osteoarthritis and back pain are not. An analysis of multimorbidity using QoF data alone –  
as the authors recognise – underestimates the prevalence of multimorbidity.
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Future prevalence
Over the next decade, the number of people 
with a long-term condition is expected to 
remain relatively constant at around 15 million 
in England, but the number of people living with 
more than one long-term condition is predicted 
to increase.52 There will also be greater numbers 
of older people: by 2035/36, the numbers of 
people over 65 is estimated to grow by 48.9%, 
with the over 85 year olds expected to be the 
fastest growing group by 113.9% (from nearly 
1.3 million currently to 2.8 million in 2035/36).53
By 2018, it is expected there will be 2.9 million 
people living with multimorbidity, compared to 
1.9 million in 2008.52 An analysis by the Royal 
College of General Practitioners has estimated 
that by 2025 the number of people living with 
‘one or more serious long-term conditions’ in 
the UK will have increased to 9.1 million.54
Multimorbidity – in numbers 
By 65 years of age, most people have 
multimorbidity.
By 85 years of age, eight out of ten people 
have multimorbidity.
Over half of the number of people with 
multimorbidity are under 65 years of age. 
Women have higher rates of multimorbidity 
than men.
By 2025 there will be an estimated 9.1 
million people living with one or more 
serious long-term conditions.
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3.2  
Multimorbidity impacts on quality of life 
and health outcomes 
Multimorbidity is associated with a poorer quality 
of life, reduced health outcomes and higher 
mortality rates.8, 55 People with multimorbidity 
use more treatments, more health and care 
services,55, 56 and are typically less able to 
perform everyday tasks.57
People with multimorbidity have complex 
needs that are best addressed with a 
biopsychosocial approach. This is because 
people with multimorbidity have many needs, 
stretching beyond healthcare.58 People living with 
multimorbidity need to manage their health 
while also managing their various appointments, 
prescriptions and life beyond healthcare.
Tasks to be managed when  
living with multimorbidity
Example of items for a person with  
osteoarthritis and depression 
1 The symptoms Pain, joint stiffness, fatigue, anxiety and depression.
2 The treatments Exercise, painkillers, anti-inflammatories, 
antidepressants, physiotherapy, counselling  
and hydrotherapy.
3 The administration of healthcare Face-to-face appointments to check on health status  
(but no treatment occurs).
Travelling to and waiting for appointments. 
Coordination of picking up and managing multiple  
repeat prescriptions.
4  The administration beyond 
healthcare
Social care, and adaptations to the home, care and 
working environments. 
Management of impact on finances such as 
applications for benefits and additional resources. 
Mitigating the impact on work.
Figure 9 Management of tasks associated with multimorbidity 
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Peter, 65  
Lives with undiagnosed 
musculoskeletal pain and angina
IF I’D KNOWN 20 
YEARS AGO, I’D HAVE 
BEEN MORE CAREFUL 
WITH MY DIET AND 
LIFESTYLE
Peter’s story 
Peter lives with joint pain in his hand, which is 
often accompanied by numbness. The cause 
of pain remains undiagnosed as Peter feels he 
already takes up a lot of his GP’s time. Along 
with joint pain, he also manages angina. 
These conditions have developed over the last 
five years. 
Peter is keen to do all he can to manage these 
long-term conditions himself and he follows a 
strict diet. However, the interaction between 
Peter’s conditions can impact on his ability to 
self-manage, particularly in terms of exercise. 
Peter enjoys cycling, but the joint pain and the 
numbness in his hands make cycling difficult. 
Peter also has to be mindful of undertaking 
strenuous exercise because of his angina.
He is concerned about the interaction between 
the medications he is taking for both conditions. 
To improve the situation of people living with 
multimorbidity, Peter would like to see the 
following changes to the health system. 
“I wish there were screenings much earlier 
around heart disease and musculoskeletal health, 
and monitoring to assess changes in conditions 
related to changes in lifestyle and diet.”
He also says that more needs to be done to 
empower people to manage their conditions, 
such as the provision of good information about 
different conditions and better information 
around physical activity, particularly information 
that considers multimorbidity. 
Peter’s final ask is for shorter waiting times for 
referrals to specialist services which he feels 
would be helpful for managing his conditions.
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is how Simon describes  
living with multiple  
long-term conditions.
Simon’s story
Simon developed joint problems when he was 18 
months old, and he was diagnosed with juvenile 
idiopathic arthritis when he was three. While 
moving to high school, Simon found out he also 
had Crohn’s disease. He has now been diagnosed 
with fibromyalgia too. 
Simon experiences hypersensitivity and extreme 
fatigue, and constant daily pain leaves him 
unable to stand for long periods of time.
He worries that the invisible nature of the 
conditions he lives with means they are often not 
recognised or understood by other people. Simon 
feels that attitudes are slowly changing, but a 
daily challenge he faces is the misunderstanding 
that arthritis only affects older people. Simon 
has endured his juvenile idiopathic arthritis and 
fibromyalgia for so long that he can manage 
them more easily than his Crohn’s which requires 
him to constantly plan every aspect of his life.
Simon has a hugely positive attitude to 
managing multimorbidity, even though he is 
no longer able to take part in contact sports. 
However, he feels that more could be done to 
improve continuity of care, particularly around 
the transition from child to adult services which 
can cause great upheaval. 
Simon believes that a few changes in the 
healthcare system could make life managing 
multimorbidity much easier. Interdisciplinary 
teams with open communication channels 
would lead to greater continuity of care across 
all conditions, fostering empowerment in self-
management and truly person-centred care. 
Building strong relationships with consultants 
would also support patient empowerment, but 
Simon notes he has met his own consultant 
only once in four years, and seen a multitude 
of registrars. Finally, he feels that person-
centred care that looks beyond health services 
and liaises with education and work services 
would improve his experiences and those of 
others immeasurably.
IT’S LIKE HAVING 
ANOTHER FULL-TIME 
JOB ON TOP OF  
YOUR LIFE 
Simon, 23  
Has juvenile idiopathic arthritis, fibromyalgia, 
Crohn’s disease and hypermobility.
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3.3 
Multimorbidity is having a growing 
impact on health and care services, 
society and the economy
Health and care services
Multimorbidity has a large impact on health and 
care services owing to the growing numbers 
of people affected, the complexity of care and 
the demands of the administration of multiple 
health needs. 
In primary care, people with multimorbidity are 
frequent users of services: six out of 10 (58%) 
patients have multimorbidity, but account for 
eight out of 10 (78%) GP consultations.50 People 
with multimorbidityh have nine consultations 
each year compared to four consultations for 
those without multimorbidity.50 The Royal College 
of General Practitioners (RCGP) has identified 
multimorbidity as a particular challenge of 21st 
century healthcare and that multimorbidity 
means ‘more people are sicker for longer and 
present more complex problems to their GPs and 
primary care teams’.59
In secondary care, there will be increasing 
demands on specialist older people’s services,  
as older people already have the highest rates of 
unplanned admissions to hospital.15 Also, people 
will be treated for one condition (or episode) 
who have other long-term conditions which may 
directly impact on their health outcomes. For 
example, the presence of comorbidities of other 
morbiditiesi can affect a person’s risk of mortality 
at 30 days following hip fracture surgery.60
Social care services will experience increased 
demand. This will include providing support 
after acute events, which may include delivering 
rehabilitation and preventing delayed discharge. 
Social care also encompasses support for people 
living with chronic multimorbidity who require 
help in the home. 
There are also funding implications for the health 
and care services. On average, a person living 
with three or more long-term conditions incurs 
costs of nearly £8,000 a year compared to a 
cost of £3,000 for a person living with one 
long-term condition.52 To meet the additional 
costs of multimorbidity, the NHS will need to 
find an additional £5 billion more in 2018 
compared to in 2011.52
Society and the economy
Owing to the growing numbers of people with 
multimorbidity, this phenomenon will have 
a considerable social and economic impact. 
Musculoskeletal conditions and mental health 
problems are the causes of the greatest number 
of working days lost61 and frequently occur 
together. Around three in 10 (32%) people 
of working age who have a musculoskeletal 
condition also have depression.62 People 
with a mental health problem alongside 
a musculoskeletal condition are less likely 
to be in work.62
As discussed in section 3.1, people from deprived 
areas develop multimorbidity 10–15 years earlier 
compared to those from the least deprived.8 
They also face an increased risk of having 
a mental health condition or pain disorder 
as a comorbidity.8 This could result in a 
disproportionate burden of ill health 
falling on people from deprived areas.
h Please note the precise numbers were 9.35 consultations and 3.75 consultations whose condition is part of the Quality and Outcomes Framework (QoF). 
i  The Nottingham Hip Fracture Score is a risk prediction tool for surgeons. The presence of comorbidities is one of the categories that is assessed to establish 
mortality risk ahead of surgery
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3.4  
A person-centred approach  
to multimorbidity 
People with long-term conditions say they need person-centred and coordinated care, with services 
brought together to achieve an outcome which is important to them.j Six key elements have been 
identified (see Figure 10 below).63
j  The long-term conditions coalition, National Voices, worked with people with long-term conditions, service users, representatives from service user organisations, 
and leaders of health and social care services to design this narrative. 
Figure 10 A narrative for person-centred coordinated care 
Person Centred Coordinated Care
Overarching summary
Service user perspective
My goals/outcomes
Transitions
Decision making
Care planning
Information
Communication
“I can plan my care with people who work 
together to understand me and my 
carer(s), allow me control, and bring 
together services to achieve the 
outcomes important to me.”
People living with multimorbidity need to be able 
to manage their own health and wellbeing.
A person’s ability to manage independently 
will be shaped by their symptoms, treatments 
and the administration needed. Confidence, 
knowledge and capability to manage also play 
a critical role: an assessment of this capability 
is known as ‘patient activation’.64
Three key factors have been identified by people 
with multimorbidity and healthcare professionals 
which affect engagement in self-management: 
capacity to manage: this includes having 
the time, knowledge, access to resources 
and energy to manage the tasks of 
multimorbidity independently
responsibility: which areas of disease 
management will be led by the healthcare 
professional and which by the individual
motivation: the readiness to self-manage.65
Social deprivation, or the combination of living  
with physical and mental health conditions,  
have a negative impact on all three factors.65
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Care and support planning
Care and support planning is an approach that 
people living with long-term conditions can 
use to manage their health and wellbeing. 
At the heart of care and support planning is 
a collaborative, personalised care planning 
conversation, usually between a person with 
one or more long-term conditions and a 
healthcare professional. 
The conversation brings together information 
gathered by the healthcare professional and 
the perspective of the person with the condition, 
allowing time for shared goal-setting and to 
develop and record a care and support plan. 
Rather than a single appointment, a multi-stage 
process enables information such as test results 
to be shared in advance so the person has time 
to consider their priorities, and to consult their 
family or carers if they wish to. 
Uptake of care plans remains low. Only 12% of 
people with a musculoskeletal condition or with 
a heart and circulatory condition and 28% of 
people with a mental health condition have 
a care plan.66
Shared decision-making
Shared decision-making is a collaborative process 
that occurs between a person with a health 
condition and their healthcare professional to 
enable them to reach a healthcare decision 
together. During such a conversation, a Patient 
Decision Aid may be used to help the person 
make a choice about their healthcare. Such an 
aid can enable a conversation about different 
options and can help the person and the 
healthcare professional explore the best 
choices for the individual. 
A range of decision aids are available for different 
conditions such as the NHS Shared Decision 
Making website. For more information:  
http://sdm.rightcare.nhs.uk/
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3.5  
Barriers to good person-centred care 
for people with multimorbidity
Barriers identified by people 
with multimorbidity
People with multimorbidity have identified 
barriers to good person-centred care. One 
in two people with multimorbidityk report 
a lack of information about conditions or 
treatments, poor communication between 
healthcare professionals, and waiting times to 
see a specialist.67 People with more long-term 
conditions, those who are in employment, 
and those reporting anxiety and depression 
experience more of these problems.67
On average, more than seven barriers to 
self-management have been identified by 
people living with multimorbidityl including:
limitations to finance and knowledge
limitations to physical capabilities
obtaining care logistics
interactions between the symptoms  
and treatments for conditions
the need for both emotional and 
social support
managing multiple medications.68
Participants’ responses revealed barriers to 
self-care, including physical limitations, lack 
of knowledge, financial constraints, logistics of 
obtaining care, a need for social and emotional 
support, aggravation of one condition by 
symptoms of or treatment of another, multiple 
problems with medications, and overwhelming 
effects of dominant individual conditions. 
Many of these barriers were directly related to 
having comorbidities.
k 31–91 years.
l People 31–70 years with multimorbidity.
1 in 2 
people with multimorbidity report a lack of 
information about conditions or treatments, poor 
communication between healthcare professionals, 
and waiting times to see a specialist.
Older people (65–84 years of age) with 
multimorbidity want continuity of care, clear 
communication of personalised care plans, 
a single contact and care co-ordinator, and 
convenient access to healthcare providers 
(by phone, email or in person).69 In particular, 
it is important to older people that they 
are recognised and listened to: participants 
expressed concerns about how they are told 
information, not just what they are told.69
No consistent impact of multimorbidity on 
a patient’s attitude to managing their health 
or on their experience of healthcare has yet 
been identified.70
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Barriers identified by healthcare professionals
GPs have identified four areas of difficulty in 
managing people with multimorbidity:71 
1  Disjointed healthcare: this includes 
too-short consultation times, and 
inadequate communication between 
multimorbidity care providers.
2  Inadequate guidelines and evidence-
based medicine: there are concerns that 
clinical guidelines are geared towards single 
conditions and there is uncertainty whether 
they still hold true for people 
with multimorbidity.
3  Problems delivering person-centred care: 
some GPs enjoy taking a broader view of 
patient care including non-medical and 
psychosocial issues, while other GPs believe 
such an approach increases the level of 
complexity further. 
4  Barriers to shared decision-making: 
GPs recognise the importance of drawing 
out a person’s preferences, but in practice 
find this difficult because of the complexity 
of multimorbidity, for example, when 
discussing the risks of treatment options. 
Enhanced communication skills are seen 
as important to enable clear discussion 
with patients about the interaction 
between their diseases.
GPs and nurses report tensions between 
delivering quality of care which meet targets 
and dealing with an individual’s priorities, and 
this tension is exacerbated when multimorbidity 
is present.72 Healthcare professionals find that 
consultations are too short, often meaning that 
clinical issues are dealt with in order of priority 
(as defined by the healthcare professional) rather 
than examining the holistic problems being 
experience by the individual.72 A review of five 
NICE disease-based clinical guidelinesm concluded 
that implementation of such best practice for 
a person with multimorbidity would encourage 
polypharmacy and that guidance isn’t provided 
about how to prioritise recommendations in 
order to avoid a treatment burden.n 73
Many of these difficulties in delivering care are 
familiar in managing long-term conditions. 
The presence of multimorbidity adds to the 
complexity. Continuity of relationships is more 
difficult to enable when care and responsibility 
is shared across multiple settings. This poses 
a particular challenge in primary care, where 
continuity of care – triggered in part by the large 
numbers of consultations required for people 
with multimorbidity – can be difficult.50
m  The disease guidelines examined were for the following conditions: diabetes (type two), myocardial infarction (secondary prevention), osteoarthritis, chronic 
obstructive pulmonary disease and depression.
n  NICE has since published the ‘Multimorbidity: clinical assessment and treatment’ clinical guideline which gives guidance on polypharmacy. Please see Section 8 for 
more information. 
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3.6  
Elements of a person-centred approach to multimorbidity
People with multimorbidity have diverse needs 
and therefore a person-centred approach is 
as much about how problems are addressed 
alongside what is done. It’s important to put the 
appropriate ethos in place with a focus not on 
‘What is the matter?’ but rather ‘What matters 
to you?’74 
Multimorbidity affects people’s care in different 
ways and therefore a range of approaches will 
be needed to improve care, all underpinned by a 
person-centred ethos. 
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Tools and systems National policy Local policy
Data: High-quality 
and accurate data is 
collected across settings 
and is anchored around 
the NHS number as a 
unique identifier.
Outcome measures: 
Relevant tools are 
identified to capture 
and regularly collect 
health outcomes.
Capability measure: 
Relevant tool to identify 
knowledge, confidence 
and capability to  
self-manage.
Care and support plan 
and process: Systems and 
tools in place to support 
identification of problems 
and goals.
Shared decision-making 
tools: These enhance 
decision-making. 
National standards for  
data collection.
National clinical guidelines 
for multimorbidity.
Accreditation. 
Qualifications and training.
An ongoing workforce 
commitment to change 
working practices. 
National programme to 
identify multimorbidity 
as part of a downstream 
health assessment (NHS 
Health Check).
Health promotion 
campaigns to target 
shared risk factors 
and living well with 
multiple conditions. 
A research agenda which 
reflects the reality of 
its beneficiaries. 
A quality improvement 
agenda. 
Audits on multimorbidity 
in primary care.
Pathways of care.
Local health needs: 
Identification and 
characterisation of the 
needs of people living with 
multimorbidity in the Joint 
Health Needs Assessment. 
Local assets: Funding 
and provision of facilities, 
programmes and services 
for people.
Clinical engagement in 
quality improvement: 
Segmentation of people 
with multimorbidity 
into groups with 
targeted interventions. 
Roles Activities Information and  documentation
Transparency over 
responsibilities held  
by healthcare and 
other professionals for 
various tasks.
Clarity over the 
affected person’s own 
role in managing their 
symptoms, treatments 
and administration of 
healthcare and beyond.
Continuity of care with 
one named professional 
having clear responsibility 
for overseeing a person’s 
care, particularly within 
general practice.
Holistic, person-
centred care using a 
biopsychosocial approach 
to consider together all 
of a person’s long-term 
conditions, including 
mental health, pain, 
physical function and 
quality of life, identifying 
those issues most 
important to the person.
Attention to treatment 
burden, including 
polypharmacy and 
medication adherence.
Recognition of changing 
needs, with regular review 
of the care and support 
plan at a frequency 
determined by need. 
Coordinated care, which 
encompasses the person 
being connected with 
relevant local facilities  
and services.
Recording of information 
about shared decisions in 
a mutually agreed written 
care and support plan. 
Information flowing 
seamlessly around health 
and care systems.
Figure 11  A high-quality approach to person-centred care for people with    
multimorbidity
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Tools and systems National policy Local policy
Data: High-quality 
and accurate data is 
collected across settings 
and is anchored around 
the NHS number as a 
unique identifier.
Outcome measures: 
Relevant tools are 
identified to capture 
and regularly collect 
health outcomes.
Capability measure: 
Relevant tool to identify 
knowledge, confidence 
and capability to  
self-manage.
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tools in place to support 
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and goals.
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decision-making. 
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Audits on multimorbidity 
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Pathways of care.
Local health needs: 
Identification and 
characterisation of the 
needs of people living with 
multimorbidity in the Joint 
Health Needs Assessment. 
Local assets: Funding 
and provision of facilities, 
programmes and services 
for people.
Clinical engagement in 
quality improvement: 
Segmentation of people 
with multimorbidity 
into groups with 
targeted interventions. 
Roles Activities Information and  documentation
Transparency over 
responsibilities held  
by healthcare and 
other professionals for 
various tasks.
Clarity over the 
affected person’s own 
role in managing their 
symptoms, treatments 
and administration of 
healthcare and beyond.
Continuity of care with 
one named professional 
having clear responsibility 
for overseeing a person’s 
care, particularly within 
general practice.
Holistic, person-
centred care using a 
biopsychosocial approach 
to consider together all 
of a person’s long-term 
conditions, including 
mental health, pain, 
physical function and 
quality of life, identifying 
those issues most 
important to the person.
Attention to treatment 
burden, including 
polypharmacy and 
medication adherence.
Recognition of changing 
needs, with regular review 
of the care and support 
plan at a frequency 
determined by need. 
Coordinated care, which 
encompasses the person 
being connected with 
relevant local facilities  
and services.
Recording of information 
about shared decisions in 
a mutually agreed written 
care and support plan. 
Information flowing 
seamlessly around health 
and care systems.
For this to work effectively, a set of activities needs to occur at different levels:
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MUSCULOSKELETAL  
HEALTH IS AN  
IMPORTANT 
PART OF 
MULTIMORBIDITY
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Good musculoskeletal health is an important part 
of living well with multiple long-term conditions. 
If a musculoskeletal condition is present – such 
as osteoarthritis or back pain – it has an overall 
impact on a person’s health and wellbeing. 
There are three reasons for being aware of the 
impact of musculoskeletal conditions. This is 
because they:
GOOD MUSCULOSKELETAL 
HEALTH UNDERPINS 
LIVING WELL AND 
INDEPENDENTLY WITH 
MULTIMORBIDITY.
4.1  
Musculoskeletal conditions are  
very common in multimorbidity
Because musculoskeletal conditions are very 
common, they are often found in people 
with other long-term conditions. Among UK 
primary care patients living with 10 common 
long-term conditions, painful conditions are a 
frequent comorbidity.75
Osteoarthritis, back pain and multimorbidity 
People living with a long-term condition are likely 
to have osteoarthritis. This is partly because the 
prevalence of long-term conditions increases 
with rising age, and also because osteoarthritis 
shares common risk factors such as obesity with 
other long-term conditions. For example, among 
people over 45 years who report living with a 
major long-term condition,o more than three out 
of 10 also have a musculoskeletal condition.19 
By age 65 years, almost five out of 10 people 
with a heart, lung or mental health problem 
also have a musculoskeletal condition.19 
The converse is also true, so people with a 
musculoskeletal condition are more likely to 
have another long-term condition. Four out of 
five people with osteoarthritis have at least one 
other long-term condition such as hypertension 
or cardiovascular disease.76
o  The major long-term conditions included in this analysis are: musculoskeletal conditions, diabetes, heart disease, lung problems, mental health  
and cancer in the last five years. This analysis includes people who have arthritis, back pain or both conditions. Please see Section 7.0 for methods.
1
2
3
are very common and 
are often present in 
multimorbidity
ruin quality of life for the 
person affected
cause pain and functional 
limitations which make 
it harder to cope with 
multimorbidity
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Figure 12  Prevalence of musculoskeletal conditions among people aged 45 years and  
over reporting other long-term conditions19
Figure 13  Prevalence of musculoskeletal conditions among people aged 65 years  
and over reporting other long-term conditions19
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Rheumatoid arthritis and multimorbidity
People with rheumatoid arthritis are at increased 
risk of developing another health condition, such 
as cardiovascular disease which affects around 
one in 20 (6%) people with rheumatoid arthritis.77,78
Osteoporosis and multimorbidity
People with osteoporosis are at increased risk of 
fragility fractures.79 Many long-term conditions, 
such as thyroid disease or rheumatoid arthritis, 
increase the risk of osteoporosis.80 Some 
treatments, including steroids or anti-hormone 
therapies for cancer, can also cause weakening of 
bone.81, 82 Some people with multimorbidity are 
at greater risk of a fragility fracture. This risk rises 
further if people with multimorbidity develop 
frailty and are at risk of falls. Multimorbidity also 
affects recovery after a fracture. 
Mental health, musculoskeletal conditions  
and multimorbidity 
Musculoskeletal conditions and mental health 
have a complex and reciprocal relationship, each 
exacerbating the other. Living with a painful 
condition can lead to depression and anxiety. 
Conversely, psychological distress and depression 
worsen pain. A cycle can therefore develop, with 
ever-worsening pain and low mood leading to 
social withdrawal and isolation. 
People with mental health conditions may 
delay seeking treatment, and clinicians may 
overlook physical symptoms, attributing these 
to an individual’s mental health condition. 
Musculoskeletal conditions are exacerbated 
by weight gain which is a common side effect 
of many medications used to treat mental 
health problems.83
Depression is the most common comorbidity 
among people with rheumatoid arthritis, 
affecting one in six people.77, 84 The presence of 
depression alongside rheumatoid arthritis can 
also lead to a person’s pain and overall disability 
being worse.85
Deprivation, musculoskeletal conditions and 
multimorbidity
The burden of ill health falls disproportionally 
on those from the most deprived areas. 
Musculoskeletal conditions and multimorbidity 
are more prevalent in more deprived populations 
compared to the least deprived populations.8,19  
In the most deprived populations, painful 
conditions are the most common multimorbidity 
among those already living with heart disease, 
diabetes, chronic obstructive pulmonary disease 
(COPD) and cancer.8
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Musculoskeletal conditions as part of 
multimorbidity – in numbers 
Painful conditions are frequently found as a 
comorbidity in 10 common conditions in UK 
primary care patients.
Four out of five people with osteoarthritis 
have at least one other long-term condition 
such as hypertension, cardiovascular disease 
or depression.
Among people over 45 years who report 
living with a major long-term condition, 
more than three out of 10 also have a 
musculoskeletal condition.
By age 65 years, almost 5 out of 10 people 
with heart, lung or mental health problem 
also have a musculoskeletal condition.’
The presence of any long-term condition 
is associated with a drop in quality of life 
(self-reported Quality of Life score of 0.79), 
but if arthritis or back pain is present as 
one of the long-term conditions the drop 
is greater (self-reported Quality of Life 
score of 0.71).
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4.2  
Musculoskeletal conditions  
ruin quality of life 
People with arthritis often live with pain, fatigue, 
depression and functional limitations, all of which 
reduce quality of life, limiting the ability to cope 
and undertake everyday activities. 
Self-reported Quality of Life (QoL) scores can 
measure the personal impact of long-term 
conditions. Compared with those without a 
long-term condition (QoL score 0.90), people 
living with one or more non-musculoskeletal 
long-term conditions report substantially 
lower quality of life (QoL score 0.79).
There is a further reduction in quality of life 
(QoL score 0.71) among those who have a 
musculoskeletal condition (arthritis or back pain) 
as part of their long-term multimorbidity. Indeed, 
the impact of musculoskeletal conditions is so 
great that people living with arthritis or back 
pain report a similarly reduced quality of life 
irrespective of whether arthritis or back pain is 
their only condition (QoL score 0.68) or is one 
among multimorbidity (QoL score 0.71).19 
Arthritis, back pain, neurological problems and 
mental health conditions have the greatest 
impact on health-related quality of life at an 
individual level.49,86 Due to the high prevalence 
of arthritis, back pain and depression, these 
conditions have the largest impact on health-
related quality of life at a population level.49,86
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Figure 14  Average Quality of Life scoresp for people aged 45 years and over who  
live with long-term conditions19
p  The EQ-5D was used. It is a questionnaire that can be used to measure health-related quality of life. It can be used as a measure of health status and provides  
a value between 0–1, with a higher score indicating a better health-related quality of life.
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Jack’s story 
Jack was diagnosed with asthma at five months 
old; now 65, he is managing a number of 
conditions, including osteoarthritis, depression, 
carpal tunnel syndrome, an underactive thyroid, 
diabetes, cataracts, an enlarged prostate 
and problems with his gall bladder. He has 
a colostomy bag as the result of surgery for 
colon cancer.
He has a high level of motivation when 
managing his many conditions, but his quality of 
life is affected by his mobility and independence: 
“It is the arthritis, the carpal tunnel and the 
bladder control… they are the things that really 
affect my quality of life.” 
Getting up and staying mobile each day are 
constant challenges for Jack, and his routine 
consists of physiotherapy exercises, multiple 
medications and dealing with personal care. 
Jack is motivated by having short-, medium- and 
long-term goals. Jack’s short-term goals include 
nights out with friends and his longer-term goals 
involve studying and going abroad: these goals 
and aspirations provide daily inspiration for 
Jack to improve his mobility and stability. 
As Jack’s relationship with the health system 
began at a young age, he has become an expert 
in self-management: “I’ve been self-managing 
my asthma for 50–odd years.” But he thinks 
the current system doesn’t support people 
as much as it could. Jack emphasises the lack of 
coordination within the healthcare system. Over 
the course of one month, Jack had 13 medical 
appointments including routine engagements 
with his GP and physiotherapist, a pre-surgery 
appointment and group talking therapy. He finds 
the burden of appointments time consuming 
and wearing even in retirement, and he 
acknowledges it must be extremely difficult for 
people who also have to work. Coordinating the 
management of medication is also an issue for 
Jack. “I’ve got four pages of repeat prescriptions, 
of about 13 different medications, plus non-
pharmacological items to help manage blood 
sugars and my colostomy. The trouble is they 
all get out of sync, so I am in and out of the GPs 
ordering repeat prescriptions and picking stuff  
up from the pharmacy virtually every week.” 
Jack says it would help if there were a single 
person who had an overview of all his conditions 
who he could go to for advice. “The only thing 
you need with self-management is someone to 
approach if you do have a problem.” 
Jack is able to approach his stoma nurse, who 
he sees in connection with his colostomy bag, 
for advice and this is a healthcare professional 
whom he can’t praise highly enough. Being 
able to build strong ongoing relationships 
with healthcare professionals, such as 
physiotherapists, is also important to Jack 
because they can understand and support 
him to self-manage.
This is Jack’s attitude in  
the face of his gruelling  
daily routine. 
IF I DID IT 
YESTERDAY I CAN 
DO IT TODAY. IF I 
DID IT TODAY I CAN 
DO IT TOMORROW.
Jack, 65  
Lives with asthma, osteoarthritis, depression, carpal 
tunnel syndrome, a colostomy bag as the result of 
surgery for colon cancer, an underactive thyroid, 
diabetes, cataracts, an enlarged prostate and 
problems with his gall bladder.
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LIVING WITH 
MULTIMORBIDITY 
IS COMPLEX AND 
DEMANDING. 
4.3  
The pain and limitations of  
arthritis make it harder to cope  
with multimorbidity
Typically, people with multiple long-term 
conditions must carry out numerous 
administrative tasks to manage their health. 
Different tablets need to be taken at specific 
times of day, and others need to be taken only 
once a week. Some medications must be taken 
regularly, others only occasionally – including 
treatments to manage the side-effects of other 
tablets. People need to keep stock of their pills, 
creams, inhalers and injections, requesting 
repeat prescriptions on time from their GP, 
and visiting the pharmacy to collect items. 
Beyond this, some conditions and treatments 
need regular blood tests or blood pressure 
measurement and monitoring, some of which 
can be done at home, some at the GP and 
some only at the hospital. 
People living with multimorbidity often see an 
array of health and care professionals at home, 
in the community and in hospitals. A typical 
week could include visits to the GP surgery and 
to one or more hospitals to see specialists; home 
visits from a district nurse, a social worker and 
formal and informal carers; and physiotherapy 
and podiatry appointments. Often there are 
no shared care records, so the person receiving 
care becomes responsible for updating each 
professional on what the others are doing. 
Receipt of benefits requires further paperwork, 
meetings and assessments. 
Beyond all this, to stay healthy, people with 
multimorbidity need to find time to shop for and 
prepare nutritious food, make time for regular 
physical activity, maintain social networks of 
family and friends, and often themselves act 
as carers for parents, partners and children. 
People’s ability to cope with these tasks is 
influenced by their confidence, knowledge and 
capability. It is also affected by whether arthritis 
is one of their long-term conditions. 
People with arthritis have physical limitations 
which make everyday tasks harder,87 summarised 
in the box on the following page. Arthritis makes 
multimorbidity much more difficult to cope 
with. Comorbid arthritis and back problems 
are responsible for a substantial proportion 
of restrictions in activity among people living 
with cardiovascular disease, diabetes and 
respiratory disease.88
People with arthritis experience fluctuations 
in their condition which make planning ahead 
difficult. This directly affects their ability 
to manage and cope with other long-term 
conditions. A person living with diabetes and 
severe hand arthritis may not know if they will 
be able to inject insulin tomorrow. Or a cancer 
survivor living with severe hip arthritis may 
not know if they will be able to take the bus 
to hospital appointments the following week. 
Knowing which tasks they can do on their own 
and for which they need support will vary from 
week to week. 
For a person who is just about managing in spite 
of their multiple long-term conditions, developing 
arthritis can take away their ability to cope. 
The painful, disabling and often unpredictable 
nature of these conditions can therefore lead to a 
worsening of all their other long-term conditions. 
Their overall life with multimorbidity becomes 
more difficult. 
The onset of arthritis can be a tipping point for 
people with multimorbidity, depriving them  
of their ability to maintain their health and 
independence, leading to a spiral of decline.
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4 in 10 
people with arthritis (43%) in the USA find it ‘very 
difficult’ or ‘cannot do’ at least one of the nine 
important functional activities of daily life.90
The impact of arthritis on basic tasks
The Centers for Disease Control and Prevention’s (CDC) Arthritis Program in the USA has 
identified nine functional limitations that people with arthritis report as being ‘very 
difficult’ or that they ‘cannot do’. 89
Grasping small objects        Reaching above the head
Sitting for more than two hours    Lifting or carrying 10 pounds
Climbing a flight of stairs       Pushing a heavy object
Walking ¼ mile            Standing for more than two hours
Stooping, bending or kneeling.
In 2010–2012, more than four in 10 people with arthritis (43%) in the USA found it 
‘very difficult’ or ‘cannot do’ at least one of the nine important functional activities 
of daily life.90
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Figure 15 Examples of the impact of arthritis on management of other long-term conditions
Functional limitation  
of arthritis
Task associated with 
management of  
long-term conditions
Condition Type of activity
Grasp small objects 
Give injections.  
Take tablets.  
Change bandages. 
Diabetes;  
multiple long-term 
conditions.
Treatment.
 
Walk a ¼ mile; 
stoop, bend or kneel
Undertake exercise. 
Get to health and 
other appointments.
Diabetes;  
multiple long-term 
conditions. 
Treatment and 
administration  
of healthcare,  
and beyond.
 
Reach above  
one’s head
Ability to get dressed 
independently.
Multiple long-term 
conditions.
Administration 
beyond healthcare 
(personal care). 
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4.4  
Interventions of care and support  
for people with multimorbidity
The research agenda about which specific 
models of care are effective for people 
with multimorbidity is in its early days.1, 67 
Case studies from overseas and other health 
areas, such as end-of-life care, illustrate 
a needs-based approach.
Osteoarthritis, anxiety and depression tend 
to be under-recognised and under-managed 
in primary care, but these conditions can 
exacerbate other long-term conditions. 
Long-term conditions such as diabetes and 
asthma are often treated by nurses in primary 
care, but nurses often focus solely on one 
condition and the opportunity to provide 
holistic care is lost. 
The Research Institute for Primary Care and 
Health Sciences and the Arthritis Research 
UK Primary Care Centre (Keele University) in 
partnership with North Staffordshire Clinical 
Partners, funded by the NIHR Collaborations for 
Leadership in Applied Health Research and Care 
West Midlands, is piloting ENHANCE. This trial is 
investigating the feasibility and acceptability of 
assessing and managing osteoarthritis-related 
pain, anxiety and depression during enhanced 
nurse-led routine reviews for people with 
long-term conditions.91
The ENHANCE intervention recognises that 
patients often see nurses more regularly than 
other clinicians for long-term conditions. The pilot 
study introduces mechanisms for recognition 
and initial management of joint pain, anxiety 
and depression into pre-existing interactions for 
patients. It entails a more holistic approach to 
ENHANCE:  
A HOLISTIC APPROACH  
TO MANAGING  
LONG-TERM  
CONDITIONS
long-term condition management by widening 
conversations around lifestyle, diet and exercise, 
and medication for joint pain, anxiety and 
depression at the same time as discussing other 
long-term conditions, and signposting to other 
services e.g. physiotherapy and psychological 
services. Nurses complete an EMIS template 
during the review and the nurse and patient fill  
in a summary card to record the next steps.  
The review was designed through co-production, 
using patient advisory groups, practice nurse 
advisory groups and stakeholder workshops 
where participants discussed and agreed 
the questions that should be asked in the 
review, using evidence from previous studies 
and guidelines.92, 93
The trial recruited 319 participants and 
questionnaires were completed just after the 
review and at six weeks and six months. The 
researchers audio recorded 24 consultations94 
and interviewed 20 patients who received the 
review, eight practices delivering the review and 
one GP. Analysis is ongoing and results of the 
pilot study will soon be available. 
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THE 3D STUDY:  
IMPROVING  
WHOLE-PERSON  
CARE
The 3D study aims to develop and test a new 
approach to how GP practices manage people 
with multimorbidity.95 Instead of focussing on 
each disease in isolation, the aim is to treat the 
whole person in a consistent, joined-up manner 
in order to improve their overall quality of life. GP 
practices testing this new management system 
(intervention group) will be compared with GP 
practices following the current treatment 
system (usual care or control group).
People with multimorbidity in general practices 
who are allocated to the intervention group 
will be identified and flagged on their GP’s 
computer system. A named nurse and doctor 
will be allocated to them to manage their care. 
These people will be given a card to identify 
them to reception staff who will offer longer 
appointment times. They will also be invited for 
a comprehensive ‘3D’ health review every six 
months which is designed to cover all of their 
health issues. The person with multimorbidity 
will first see their named nurse who will identify 
their concerns and priorities (Dimensions of 
health), and will perform any routine checks 
required by the person’s conditions. Their Drugs 
will be reviewed to check they are being correctly 
prescribed (without dangerous interactions) 
and taken properly: where possible, the person’s 
prescriptions will be simplified, for example by 
arranging for all of them to be taken once a day. 
The named GP will check for and treat symptoms 
of Depression. The practice will also have a 
linked ‘general physician’ at the local hospital 
whom they can contact easily for advice about 
people with complex problems. 
People with multimorbidity in general practices 
allocated to the usual care group will continue 
having their care managed by their GPs and 
practice nurses using current management 
practices of multiple appointments and 
clinics for each separate condition.
The 3D research team first tried the new 
approach in three practices and used this 
experience to improve it. The team then recruited 
33 GP practices in and around Bristol, Manchester 
and Glasgow to take part in the main study. 
These practices were randomly assigned to the 
intervention or usual care group. About 1,400 
people with multimorbidity from these practices 
will be followed up over a period of 15 months.
As part of this trial, participants from both 
groups will be asked to fill in questionnaires 
about their wellbeing, illnesses and treatments, 
their experience of their care, and what health 
resources they use at nine and 15 months. The 
research team will review the notes of people 
with multimorbidity in both groups to record 
the number, type, duration and quality of 
consultations within general practice as well 
as their use of other health and social services.
The study will compare the cost of the old and 
new approaches (both the cost to the NHS and 
the cost to the person with multimorbidity) and 
relate this to the benefit in a cost-effectiveness 
analysis. It will also interview people with 
multimorbidity and health care staff to explore 
how well the approach was implemented and 
identify potential areas for improvement. 
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The Age UK Personalised Integrated Care 
pathway is a person-centred approach that 
embeds the local voluntary sector with health 
and care organisations to support older people 
with long-term conditions.96 Every older person is 
matched with an Age UK Personal Independence 
Co-ordinator who works with the older person to 
develop an innovative combination of medical 
and non-medical support designed to enable 
them to achieve their personal goals and 
aspirations, improve their wellbeing, and manage 
their conditions effectively. Age UK works with a 
local partnership of commissioners, GPs, the local 
authority and the hospital trust to keep people 
well and to avoid unnecessary and costly 
hospital admissions.
A predictive risk stratification model is used 
within primary care to identify a specific cohort 
of older people with multiple long-term 
conditions who are at risk of unplanned 
admission to hospital. These conditions include 
angina, diabetes, stroke and dementia. Using 
a ‘guided conversation’, the Age UK Personal 
Independence Co-ordinator meets the older 
person at home and draws out the goals most 
important to them based on improving their 
overall wellbeing. They work with the older 
person to create a care plan which brings 
together services from health, social care and the 
community and support to help the older person 
to improve their confidence, social connections 
and wellbeing over a twelve-week period. This 
sometimes involves accessing services too. 
Regular monitoring of their wellbeing takes place 
before, during and after the service.  
Each older person’s care plan is reviewed 
regularly by primary care based multidisciplinary 
teams, of which the Age UK Personal 
Independence Co-ordinator is an active member.
Age UK is currently evaluating phase 2 of this 
programme to understand the experiences of 
older people, volunteers and the partnerships 
who work together to embed the service. 
The evaluation will give indications about the 
effectiveness of the programme on improving 
wellbeing, in reducing unplanned hospital 
admissions, and activity in primary care.
PERSONALISED 
INTEGRATED CARE:  
DELIVERING PERSON-CENTRED 
CARE FOR OLDER PEOPLE WITH 
LONG-TERM CONDITIONS 
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The Empowered Living Team (ELT) at St Joseph’s 
Hospice in Newham is focused on tackling 
the challenges of an ageing population with 
increasing immobility through person-centred 
rehabilitative palliative care.97
The ELT intervention aims to empower people 
managing their conditions with a focus on living 
well alongside debilitating conditions. The ELT 
utilises training and volunteers so that patients 
can be supported in their own homes.
The ELT offers support through rehabilitation 
programmes alongside complementary 
therapy, emotional support and befriending. 
This encourages patients to be empowered in 
managing their conditions, through promoting 
understanding and independence as much 
as possible. 
In the pilot phase, most participants benefited 
from improved health outcomes and improved 
levels of engagement and empowerment: 
12 out of 19 patients saw improvements in 
their mobility status and level of function 
10 out of 19 patients showed an increased 
confidence to self-manage their main 
symptoms
11 out of 16 patients showed an increase in 
their personal wellbeing scores. 
This model offers a new dynamic for how people 
can be in control of their conditions, as well as a 
model for demonstrating how person-centred 
care can be achieved across different areas 
of care. 
EMPOWERED 
LIVING TEAM:  
PERSON-CENTRED 
REHABILITATIVE PALLIATIVE CARE
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The Health and Employment After Fifty (HEAF) 
study comprises 8,000 people aged 50–64 years 
from 24 general practices across England.98 
Each person answers a baseline questionnaire 
covering demographics, health, wellbeing, 
retirement aspirations, employment history, 
current work status and health-related job loss 
as well as other areas. Participants will repeat the 
questionnaire at regular intervals, initially over a 
five-year period. 
Set against the context of ageing populations, 
declining birth rates and slowing economic 
growth, many European governments are 
finding fiscal incentives to encourage workers to 
work into older age. This raises many questions 
around whether it is healthy for people to work 
longer. The HEAF study seeks to address core 
questions relating to this, including the impact 
of common health conditions on work capability 
and work participation at older age; the social, 
occupational, personal and medical co-factors 
which influence vocational outcomes among 
older people; and the impact of job loss (age 
related or health related) on the subsequent 
physical and psychological health of people 
aged over 50 years. 
The HEAF study is funded by Arthritis Research 
UK, the Medical Research Council and the 
Economic and Social Research Council. The 
data collected includes variables that could 
influence work participation including sense 
of achievement, job satisfaction, feeling 
appreciated, friendship at work and worry 
over work. It also gathered personal factors 
such as finances and savings, pensions 
entitlement, retirement expectations, and caring 
responsibilities. One part of the questionnaire 
looks at the Fried frailty criteria, and captures 
frailty and participation in the workplace as 
part of its data. 
Findings so far include that at least two of the 
five components of frailty were reported by one 
in three adults between 50 and 64 years of age. 
Frailty is highly associated with inability to work 
in the 50–64 years of age group, particularly for 
a health-related reason. The conclusion was that 
interventions that are successful in maintaining 
muscle strength, function and minimising frailty 
could have important effects on economic 
productivity as well as on health and 
wellbeing in later life.
THE HEALTH  
AND EMPLOYMENT 
AFTER FIFTY STUDY: 
UNDERSTANDING BARRIERS  
TO WORKING 
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RECOGNITION OF 
MUSCULOSKELETAL 
HEALTH AS PART OF 
MULTIMORBIDITY
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5.1  
Musculoskeletal conditions fail  
to be recognised at many levels 
Arthritis and musculoskeletal conditions have 
been missed on many occasions, despite their 
great impact. This was acknowledged by the 
Chief Medical Officer for England who described 
osteoarthritis as ‘an unrecognised public health 
priority’.99 People with arthritis have noticed the 
lack of recognition of their condition within the 
health service and across society.20
Figure 16 Examples of areas in which musculoskeletal conditions have not been recognised
Level Description
Individual Six out of 10 people (62%) with arthritis do not believe their condition is 
a high priority for the NHS.20
Nine out of 10 people with arthritis (89%) agree that society views 
arthritis as an ‘old person’s disease’.20
Only 12% of people with a musculoskeletal condition have a care and 
support plan.66
Healthcare 
professionals and 
other professionals
Musculoskeletal conditions are under-recognised in undergraduate 
curricula in medical schools, postgraduate medical training100 and  
pre-registration training for nurses.
Only rheumatoid arthritis and osteoporosis are included in the incentive 
scheme Quality and Outcomes Framework.q 
Healthcare professionals may not see musculoskeletal conditions as a 
priority in clinical consultations, or may experience uncertainty about 
how to manage and support self-management of these conditions. 
Healthcare and other professionals may perceive osteoarthritis as an 
inevitable part of becoming older and therefore nothing can be done.
q Only measures relating to osteoporosis and rheumatoid arthritis are included in the Quality and Outcomes Framework.
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Local level Local prevalence data for major musculoskeletal conditions has not 
been routinely published and therefore communities have struggled  
to identify the health needs of their local population.r 
One out of four local authorities has missed arthritis from its Joint 
Strategic Needs Assessment in England.s,101
Only one local authority in England has mentioned osteoarthritis in its 
Joint Health and Wellbeing Strategy.101
Only 37% of hospitals are linked to a Fracture Liaison Service in England, 
Wales or Northern Ireland.102
Access to physiotherapy and number of sessions offered varies. Only an 
estimated one-third of Clinical Commissioning Groups offer self-referral 
to physiotherapy.103
Tools and systems Musculoskeletal conditions were missed out the first extract of primary 
care data for the multi-condition Care.data programme. 
Clinical audits taking place are in rheumatoid and early inflammatory 
arthritis, and falls and fragility fractures. 
National level No national strategy for musculoskeletal conditions, since the 2006 
Musculoskeletal Services Framework.
No national public health campaigns.
Musculoskeletal conditions are not included in the NHS Health Check. 
Local areas are not obliged to implement NICE-recommended 
physical activity interventions for osteoarthritis, despite clear clinical 
and cost effectiveness.
Level Description
r  Arthritis Research UK in partnership with Imperial College London has produced prevalence estimates for knee and hip osteoarthritis, back pain,  
rheumatoid arthritis and fragility fractures. 
s Only 36% of Joint Strategic Needs Assessments have specifically included osteoarthritis and only 38% have included back pain. 
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THERE ARE A NUMBER  
OF UNDERLYING REASONS 
FOR THE LACK OF 
RECOGNITION. 
Firstly, national policy has given a greater focus 
to conditions resulting in early death (mortality) 
rather than those which reduce quality of 
life (morbidity). Such a focus alongside other 
measures has had an impact: over the last 
15 years, outcomes for cardiovascular disease 
and cancer have improved.104
Secondly, musculoskeletal conditions have 
experienced the nihilistic perception that nothing 
can be done, that arthritis is an inevitable part of 
ageing, and that people should just put up with 
their joint pain.20
Finally, the nature of musculoskeletal conditions 
means there are no biomarkers or simple tests 
to capture a person’s musculoskeletal health. 
The lack of simple outcome measurest means a 
lack of data about people with these conditions. 
Because measurement drives activity, policy 
focus is often on surgical and orthopaedic 
services for people with severe arthritis, with 
a relative neglect of primary and community 
care, where the majority of musculoskeletal 
conditions are dealt with.
Recognition of musculoskeletal health as part 
of multimorbidity is important because good 
musculoskeletal health underpins independent 
living with multiple long-term conditions. Without 
such recognition, musculoskeletal conditions will 
exacerbate and help accelerate a number 
of trends. 
5.2  
Ways to recognise musculoskeletal health 
as part of multimorbidity 
People are living longer, but also living longer 
with ill health.105 Policymakers will therefore 
need to consider how to prolong healthy life 
expectancy and to work with partners to create 
a positive vision of meaningful, fulfilling older life. 
Financial restraints continue to exert pressures 
on health and social care. An ageing population, 
combined with growing levels of obesity and 
physical inactivity, will trigger an increase in 
the numbers of people living with arthritis. 
If the impact of musculoskeletal conditions 
continues to be unaddressed, then poor 
musculoskeletal health will reduce people’s 
ability to live independently. This, alongside 
multimorbidity, may overwhelm health 
and care systems. 
But, this lack of recognition is not inevitable.
Positive steps can be taken to recognise and 
address musculoskeletal conditions when they 
are present as part of multimorbidity. Such 
recognition should occur at many levels. 
t  The Musculoskeletal Health Questionnaire (the MSK–HQ), a patient-reported outcome measure, became available in 2016. For more information please see:  
http://www.arthritisresearchuk.org
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Figure 17  Overview of levels of recognition needed of musculoskeletal health as part 
of multimorbidity 
Level Description
Individual People with multimorbidity need to be aware of the impact of 
musculoskeletal health on their wellbeing and independence.
People should know how to take care of their joints, bones and muscles.
Healthcare 
professional and 
other professionals
When assessing the needs of a person with multimorbidity, 
professionals should have the competencies to:
be able to identify that a person has a musculoskeletal condition 
understand the bio-psycho-social impact
be aware of how a musculoskeletal condition impacts on activities 
of daily living, instrumental activities of daily living and ability to 
live independently. 
Healthcare professionals should know how to support the person to 
change their behaviour and how to support them into sustained self-
management. 
Local planners Able to identify the needs of the local population.
Ensure appropriate services are provided. 
Voluntary sector in local area needs to be aware of the impact  
of pain on people’s functional abilities. 
Tools and systems Tools and systems used to collect and manage information and data 
about people with multimorbidity should include musculoskeletal 
conditions.
National level Policymakers should consider how they can support healthy ageing, 
identification of pain, and living independently with multimorbidity.
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Individual level
Tackling misconceptions about arthritis
People with multimorbidity should have access 
to high-quality information and support. These 
should address common misconceptions about 
arthritis: for example, it must be made clear that 
arthritis is not an inevitable part of getting older 
and that there are self-management steps that 
people can take. In particular, they should be 
encouraged to use physical activity to manage 
pain. Information and advice should be made 
available through public health campaigns, and 
through initiatives such as Making Every Contact 
Countu using face-to-face and online methods. 
People can share their experiences directly 
with others through peer support. Personalised 
support from professionals can be delivered 
through care and support planning. All of these 
can be supported through partnerships between 
health and care services and the third sector.
Health, care professionals and 
other professionals
Identifying pain and appropriate signposting
Healthcare and other professionals should be 
alert to the presence of chronic pain among 
people with multimorbidity.106 Curriculum and 
training systems should enable healthcare 
professionals (including GPs, nurses and 
physiotherapists) to consider and assess the 
impact of ‘the physical, psychological, social, 
occupational and financial impact’ of painful 
arthritis.107 Other professionals, including those 
working in social care or community pharmacy, 
should be able to provide appropriate brief advice 
and signposting for people with multimorbidity 
who also have arthritis. 
Supporting health and care decisions
People’s problems and goals should be assessed 
using a biopsychosocial approach, captured in a 
care and support plan. The assessment should 
include screening for musculoskeletal symptoms, 
including consideration of the impact of arthritis 
pain and disability. When supporting people 
to identify their health goals, health and care 
professionals should ensure people have the 
information they need to make decisions about 
improving their musculoskeletal health. There 
must be clarity about who will be responsible 
for carrying out the different actions outlined 
on the plan.
u   A PHE resource for allied health professionals has been developed in partnership with the Arthritis Research UK Primary Care Centre at Keele University for Making 
Every Contact Count for back pain. The resource is available at http://meccback.co.uk/back-pain-the-facts/
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CASE STUDY: THE ROLE 
OF HEALTHCARE AND 
OTHER PROFESSIONALS 
IN IDENTIFYING PAIN
Living with pain reduces quality of life. Healthcare 
and other professionals have a role to play in its 
identification, assessment and treatment. 
The Absent Healthcare Professional published 
by Arthritis Research UK,108 proposes a way of 
working for healthcare professionals whereby 
there are ‘three Es’ of basic advice which should 
be given in relation to the care of people when 
arthritis is present: 
education
exercise
easing pain.
The Royal College of Nursing has published a pain 
knowledge and skills framework for the nursing 
team in which it recognises that ‘assessing and 
managing pain are essential components of 
nursing practice’.109
The Royal College of General Practitioners’ 
curriculum on care of people with 
musculoskeletal conditions stresses 
‘understanding that reducing pain and disability 
rather than achieving a complete cure could 
be the goal of treatment.’107
NICE’s ‘Multimorbidity: clinical assessment 
and management’ clinical guideline stresses 
that healthcare professionals should ‘be alert 
to the possibility… of chronic pain and the 
need to assess this and the adequacy of pain 
management.’106 NICE also recently published 
social care guidance which recommends that 
health and social care practitioners should be 
able to ‘recognise, consider the impact of, and 
respond’ to a number of conditions including 
chronic pain.128
There is the potential to ensure that all workers 
who come into contact with the public are aware 
of the impact of pain. Such an approach could 
include the ability to identify if a person is in 
pain; awareness that pain can act as a barrier 
to being physically active; and signposting to 
appropriate information and support. Such an 
approach should be included in the Making Every 
Contact Count resources and within the Career 
Framework for those working at levels 1–3. 
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CASE STUDY: CONNECTING 
PEOPLE FROM IN THE 
HEALTH SERVICE TO 
LOCAL SERVICES
The Scottish Government is funding the National 
Links Worker Programme in which ‘links workers’ 
based in GP surgeries support and connect 
people with complex needs to local information, 
services and support. The programme is being 
delivered by the Health and Social Care Alliance 
and GPs at the Deep End, with partners including 
the Royal College of General Practitioners and the 
Scottish Association for Mental Health.110
Age UK, with support from the Big Lottery 
Fund, is supporting Care Navigators in the Isle 
of Wight who support people to identify their 
goals and to access appropriate services to meet 
their needs.111
In Tower Hamlets, the Bromley-by-Bow Centre 
has a well-established programme of social 
prescribing to support people living with chronic 
illness to improve their confidence, learn new 
skills, find work and transform their lives.112 
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v This campaign is targeted at 40–60 year olds. 
National level
Improving quality, coverage and flow of data
High-quality data on musculoskeletal conditions 
and multimorbidity should be routinely obtained 
and used across public health, health and 
care, and other related systems. Such data 
should enable commissioners to identify the 
scale and needs of people with multimorbidity. 
Clinical activity, outcome and patient activation 
data can support service delivery and quality 
improvement activities. Improving the flow of 
patient information and data between services, 
alongside good governance, should be prioritised. 
Data on musculoskeletal conditions should be 
included and then published in relevant analyses 
of multimorbidity.
Public health
Public health information, programmes and 
campaigns should recognise and address 
the needs of the growing numbers of people 
living with multimorbidity and musculoskeletal 
conditions. The impact of pain and functional 
limitations on physical activity and independence 
should be taken into consideration when 
designing, implementing and evaluating public 
health information, programmes and campaigns. 
For example, the One You campaign, which 
focuses on healthy living in adult lifev, provides a 
platform from which the changing nature of the 
UK’s population and their public health needs 
can be addressed. 
Local health and care system
Local services and programmes
Local authorities and clinical commissioning 
groups should identify, segment and understand 
the needs and requirements of people living with 
musculoskeletal conditions and multimorbidity in 
their population. Barriers should be identified that 
could limit the access of people with arthritis and 
musculoskeletal conditions to local programmes. 
Physical barriers need to be considered – such as 
the ease of entering and navigating buildings – 
along with other barriers, such as a person being 
unaware of the facilities available. Local data and 
the agreed approach should be captured in Joint 
Strategic Needs Assessments and Joint Health 
and Wellbeing Strategies. 
Ensuring connectivity between health and 
local services should be given particular 
attention. Many people with multimorbidity 
will have needs which range beyond their 
health, such as a wish to access benefits and 
work-training programmes. Social prescribing 
(building links between patients and community 
support) should be harnessed by the Clinical 
Commissioning Group and its Local Authority 
counterpart(s) by identifying and enabling 
signposting and connecting services.
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Role of the third sector
Disease-specific charities and their respective 
coalitions should recognise that many people 
now live with multimorbidity and should develop 
relevant resources, programmes, research 
and partnerships to meet the changing needs 
of their beneficiaries. The charity sector is a 
substantial contributor to health and care 
support: there are nearly 36,000 health and 
social care charities in the UK, spending around 
£4,522 million on health in 2013/14.113 Many of 
these organisations support individuals directly, 
and/or support the health and care system.114 
As health and care services start to contend 
with the implications of multimorbidity, leading 
coalitions such as National Voices and the 
Richmond Group of Charities have opportunities 
to bring charities together to identify ways of 
working, including developing policy, providing 
information and support, and delivering models 
of care which reflect the needs of people living 
with multimorbidity. 
Multimorbidity research agenda
Researchers should develop a framework 
so that the phenomenon of multimorbidity 
can be analysed. Areas of research should 
include prevalence, models and pathways of 
care, outcome measures, and the attitudes of 
people and healthcare professionals towards 
multimorbidity; such analyses should seek 
to include musculoskeletal diseases, where 
possible. Multimorbidity research should 
reflect the prevalence and impact of diseases 
and conditions, including musculoskeletal 
conditions, and emphasise the goal of healthy 
life expectancy. 
The National Institute for Health Research (NIHR) 
has already issued a research call for evaluation 
of interventions or services for older people with 
multimorbidity.115 Along with sector bodies such 
as the Association of Medical Research Charities, 
research funders such as the NIHR should play 
a role in facilitating cross-sector conversations 
to enable the multimorbidity research agenda 
to flourish. 
Sharing best practice 
Innovations and new models of care, 
which include consideration of a person’s 
musculoskeletal health, should be widely 
and systematically shared to improve health 
outcomes for people with multimorbidity. 
Effective interventions should be brought 
together, curated and disseminated at a national 
level. For example, NHS England and the Coalition 
for Collaborative Care have launched a handbook 
to support personalised care and support 
planning.116 There are opportunities for regional 
Academic Health Science Networks to spread 
their knowledge and showcase interventions 
beyond their locality. Particular attention should 
be given to bring together evidence which 
satisfies local decision-makers: for example, local 
commissioners may require evidence relating 
to the development of their business case and 
improvements in health outcomes in relation 
to cost savings. 
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A NUMBER OF CHANGES 
SHOULD BE MADE TO 
ENSURE RECOGNITION OF 
MUSCULOSKELETAL HEALTH  
AS PART OF MULTIMORBIDITY:
NHS England should ensure that 
any metrics and tools used in 
multimorbidity programmes include 
monitoring and measuring of pain 
and its impact, functional abilities 
and capability to manage.
1/ Identification: 
Public Health England should work 
with other national bodies to ensure 
that data collection, analysis and 
publication raises awareness of 
multimorbidity and the relevance of 
its musculoskeletal component.
2/ Data Collection: 
Local planners and commissioners 
of health and care services should 
identify, segment and understand the 
needs and requirements of people 
living with musculoskeletal conditions 
and multimorbidity in their population, 
and publish these in local documents 
such as their Joint Strategic Needs 
Assessments and Joint Health and 
Wellbeing Strategies.
3/ Planning and Commissioning: 
Healthcare providers should ensure that 
people with multimorbidity can take part 
in a care and support planning process 
using standardised tools to explore and 
record pain, functional limitations and 
how these affect their daily activities.
4/ Care and Support Planning: 
Public Health England should ensure 
that its information, programmes and 
campaigns reflect and address the needs 
of the growing numbers of people 
living with multimorbidity including 
musculoskeletal conditions.
5/ Health Promotion: 
Research funders, such as the National 
Institute for Health Research, should 
work with partners to ensure there 
is a flourishing research agenda 
covering multimorbidity, which 
includes common conditions such as 
musculoskeletal conditions.
7/ Research Agenda: 
Disease-specific charities and their 
respective coalitions should collaborate 
in recognising that many people now live 
with multimorbidity and work together to 
develop resources, programmes, research 
and partnerships to meet the changing 
needs of people with multiple long-
term conditions.
6/ Voluntary Sector: 
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The GP Patient Survey
The GP Patient Survey (GPPS) assesses patients’ 
experiences of access to and quality of care 
received from local GPs, dentists, out-of-hours 
doctor services and NHS primary care services 
in England. Patients’ general state of health is 
also recorded. The survey is sent twice a year (in 
January and July) across two waves of fieldwork 
to approximately 2.7 million randomly selected 
adult patients registered with a GP in England; 
participation is voluntary.
The GPPS includes questions for patients to 
self-report whether they have been diagnosed 
with ‘arthritis or long-term joint problem’ 
(referred to in our analysis as ‘arthritis’) and 
‘long-term back pain’ (referred to in our analysis 
as ‘back pain’). This data can be used to 
provide an estimate of the prevalence of these 
conditions. However, it should be noted that 
such estimates should be treated with care, since 
they rely on patient reports of doctor-diagnosed 
conditions and not directly on medical records. 
All data is weighted to the English population.117
Our current findings are from wave 2 (W2) of the 
eighth year of the survey (June–September 2014). 
There were 903,357 respondents in the set, out 
of whom 812,168 (89.91%) gave valid responses 
to the questions about arthritis or back pain. 
All the results in our analyses include 95% 
confidence intervals.
National survey of people with arthritis
A nationally representative online survey of 
2,540 people with arthritis from across the UK 
was carried out during September 2015. The 
survey included people living with inflammatory 
conditions such as rheumatoid arthritis, 
musculoskeletal pain such as osteoarthritis, 
and osteoporosis. 
For more information, please see the report 
Living well with arthritis: identifying the unmet 
needs of people with arthritis (2015 unpublished), 
commissioned by Arthritis Research UK and 
delivered by Revealing Reality (ESRO).
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Table 1 Relevant NICE guidance in relation to musculoskeletal conditions and multimorbidity
Title Date Ref Type Content relevant to musculoskeletal conditions and multimorbidity
Hip fracture: the 
management 
of hip fracture 
in adults118
June 
2011
CG124 Clinical 
guideline
This guideline recognises that around 
10% of people with a hip fracture die 
within one month and that around 
one-third of people die within 12 
months. The majority of these deaths 
are owing to an associated condition 
rather than the fracture itself. This 
is a reflection on the numbers 
of comorbidities among people 
experiencing a hip fracture. 
Immediately identify comorbidities 
to ensure that surgery is not delayed. 
(1.2.2)
Low back pain 
and sciatica 
in over 16s: 
assessment and 
management119
Nov 
2016
NG59 Clinical 
guideline
No specific mention of multimorbidity.
Low back pain120 Exp 
pub. 
Jul 
2017
QSD Quality 
standard
Under development. 
THERE ARE A NUMBER OF RELEVANT NICE GUIDELINES 
ON MANAGEMENT AND CARE OF PEOPLE WITH 
MUSCULOSKELETAL CONDITIONS AND/OR  
MULTIMORBIDITY:
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THERE ARE A NUMBER OF RELEVANT NICE GUIDELINES 
ON MANAGEMENT AND CARE OF PEOPLE WITH 
MUSCULOSKELETAL CONDITIONS AND/OR  
MULTIMORBIDITY:
Osteoarthritis: 
care and 
management 
in adults121
Feb 
2014
CG177 Clinical 
guideline
If a person has more than one 
comorbidity, consider an annual review.
When developing a management plan, 
take into consideration comorbidities 
which compound the impact of 
osteoarthritis. (1.2.3)
Discuss risks and benefits of different 
treatments, taking into account any 
comorbidities. (1.2.4)
Exercise for osteoarthritis should 
be considered a core treatment 
irrespective of age, comorbidity, pain 
severity or disability. (1.2.5)
Factors specific to the patient, including 
comorbidities, should not be barriers 
for referral for joint replacement 
surgery. (1.6.5)
Osteoarthritis122 June 
2015
QS87 Quality 
standard
Stresses the important of a holistic 
assessment which includes 
consideration of the impact 
of comorbidities. 
Exercise is a core treatment for adults: 
if comorbidities are perceived as a 
barrier to this, then specific advice and 
encouragement should be given.
When considering a person’s BMI, it’s 
important to understand comorbidity 
risk in older people.
Comorbidities should not be a barrier 
to referral for consideration of joint 
replacement surgery. 
Osteoporosis: 
assessing the 
risk of fragility 
fracture123
Aug 
2012
CG146 Clinical 
guideline
Residents in care homes have a high 
risk of fragility fractures. Reasons 
for this include age and fragility 
with multimorbidities.
Title Date Ref Type Content relevant to musculoskeletal conditions and multimorbidity
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Title Date Ref Type Content relevant to musculoskeletal conditions and multimorbidity
Rheumatoid 
arthritis: the 
management 
of rheumatoid 
arthritis in 
adults124
Apr 
2009
CG79 Clinical 
guideline
Offer an annual review, including 
checking other comorbidities. (1.5.1.4)
For newly diagnosed people 
with comorbidities, combination 
disease-modifying anti-rheumatic 
(DMARD) therapy may not be 
appropriate. (1.4.1.4)
Rheumatoid 
arthritis in 
over 16s45
June 
2013
QS33 Quality 
standard
Medical management with drugs 
reduces the risk of developing 
comorbidities. 
Monotherapy should be used for 
people with newly diagnosed 
rheumatoid arthritis where 
combination disease-modifying 
drug therapy is not possible owing 
to comorbidities. 
An annual review should encompass 
checking for the development of 
comorbidities such as heart disease, 
depression, osteoporosis and 
hypertension (some aspects of which 
can occur in primary care).  
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Title Date Ref Type Content relevant to musculoskeletal conditions and multimorbidity
Table 2 Relevant NICE guidance in relation to multimorbidity
Medicines 
optimisation125
March 
2016
QS120 Quality 
standard
This Quality Standard highlights the safe  
and effective use of medicine across:
shared decision-making.
patient involvement in reporting 
medicines-related patient safety incidents.
learning from medicines-related patient 
safety incidents.
medicines reconciliation in acute settings.
medicines reconciliation in primary care.
structured medication review.
Multimorbidity: 
clinical 
assessment 
and 
management106
Sept 
2016
NG56 Clinical 
guideline
This guideline is targeted at the clinical 
assessment and management of people with 
multimorbidity. The guideline encompasses:
General principles. (1.1)
Identifying, principles and tailoring 
an approach to care which considers 
multimorbidity. (1.2, 1.3, 1.5) Such an 
approach would include consideration of:
disease and treatment burden
patient goals, values and priorities
review of medicines and other 
treatments
an individualised management plan.
Assessment of frailty. (1.4)
The guideline encourages healthcare 
professionals to be alert to the possibility 
of: (1.6.5)
depression and anxiety.
chronic pain and the need to assess this 
and the adequacy of pain management. 
Multimorbidity126 Draft 
available
GID–
QS10023 
(Draft)
Quality 
standard
The draft Quality Standard focuses on adults 
with multimorbidity:
being identified by their GP practices.
being assessed for frailty with specific tools.
being asked about their goals, values 
and priorities.
knowing who is responsible for their care.
having a review of their medicines and 
other treatments, and a discussion about 
whether treatments can be stopped 
or changed. 
Social care for 
older people 
with needs 
and multiple 
long-term 
conditions129
Sept 
2016
QS132 Quality 
standard
Scope: the planning and delivery of 
coordinated social care and support for 
people over 65 with multimorbidities.
Workplace 
health: support 
for employees 
with disabilities 
and long-term 
conditions
Tbc Under  
develop-
ment
NICE 
Public 
health 
guideline
A call for evidence has been issued with a 
particular focus on obtaining evidence on  
the most effective workplace interventions  
to support employees with disabilities and 
long-term conditions.
Musculoskeletal conditions and multimorbidity \ 8.0 NICE Guidelines84
Table 2 Relevant NICE guidance in relation to multimorbidity continued
Multimorbidities: 
system 
integration to 
meet population 
needs
Topic 
deferred 
until 
further 
notice
Under  
develop-
ment
Public 
health 
guidance
Scope: to be confirmed. 
Older people: 
independence 
and mental 
wellbeing127
Dec 
2015
NG32 NICE 
guideline
This guideline made a series of 
recommendations encompassing:
principles of good practice.
group-based activities.
one-to-one activities.
volunteering.
identifying those most at risk of a decline in 
their independence and mental wellbeing.
Older people 
with social 
care needs 
and multiple 
long-term 
conditions128
Nov 
2015
NG22 NICE 
guideline
This guideline made a series of 
recommendations encompassing:
identifying and addressing social 
care needs.
care planning.
supporting carers.
integrating health and social care planning.
delivering care.
preventing social isolation.
training health and social care practitioners.
Title Date Ref Type Content relevant to musculoskeletal conditions and multimorbidity
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